This document is an excerpt from the EUR-Lex website
Document 02017R2470-20230822
Commission Implementing Regulation (EU) 2017/2470 of 20 December 2017 establishing the Union list of novel foods in accordance with Regulation (EU) 2015/2283 of the European Parliament and of the Council on novel foods (Text with EEA relevance)Text with EEA relevance
Consolidated text: Commission Implementing Regulation (EU) 2017/2470 of 20 December 2017 establishing the Union list of novel foods in accordance with Regulation (EU) 2015/2283 of the European Parliament and of the Council on novel foods (Text with EEA relevance)Text with EEA relevance
Commission Implementing Regulation (EU) 2017/2470 of 20 December 2017 establishing the Union list of novel foods in accordance with Regulation (EU) 2015/2283 of the European Parliament and of the Council on novel foods (Text with EEA relevance)Text with EEA relevance
ELI: http://data.europa.eu/eli/reg_impl/2017/2470/2023-08-22
02017R2470 — EN — 22.08.2023 — 042.001
This text is meant purely as a documentation tool and has no legal effect. The Union's institutions do not assume any liability for its contents. The authentic versions of the relevant acts, including their preambles, are those published in the Official Journal of the European Union and available in EUR-Lex. Those official texts are directly accessible through the links embedded in this document
COMMISSION IMPLEMENTING REGULATION (EU) 2017/2470 of 20 December 2017 establishing the Union list of novel foods in accordance with Regulation (EU) 2015/2283 of the European Parliament and of the Council on novel foods (OJ L 351 30.12.2017, p. 72) |
Amended by:
COMMISSION IMPLEMENTING REGULATION (EU) 2017/2470
of 20 December 2017
establishing the Union list of novel foods in accordance with Regulation (EU) 2015/2283 of the European Parliament and of the Council on novel foods
(Text with EEA relevance)
Article 1
Union list of authorised novel foods
The Union list of novel foods authorised to be placed on the market within the Union as referred to in Article 6(1) of Regulation (EU) 2015/2283 is hereby established and set out in the Annex to this Regulation.
Article 2
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
ANNEX
UNION LIST OF NOVEL FOODS
Content of the list
1. The Union list shall consist of Tables 1 and 2.
2. Table 1 includes the authorised novel foods and contains the following information:
Column 1 |
: |
Authorised novel food |
Column 2 |
: |
Conditions under which the novel food may be used. This column is further subdivided into two: Specified food category and Maximum levels |
Column 3 |
: |
Additional specific labelling requirements |
Column 4 |
: |
Other requirements |
3. Table 2 includes the specifications on novel foods and contains the following information:
Column 1 |
: |
Authorised novel food |
Column 2 |
: |
Specifications |
Table 1: Authorised novel foods
Authorised novel food |
Conditions under which the novel food may be used |
Additional specific labelling requirements |
Other requirements |
►M30 Data Protection ◄ |
|
N-Acetyl-D-neuraminic acid |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘N-acetyl-D-neuraminic acid’ Food supplements containing N-acetyl-D-neuraminic acid shall bear a statement that the food supplement should not be given to infants, young children and children under 10 years of age where they consume breast milk or other foods with added N-acetyl-D-neuraminic acid within the same twenty four hour period. |
|
|
Infant and follow-on formulae as defined by Regulation (EU) No 609/2013 (1) |
0,05 g/L of reconstituted formula |
||||
Processed cereal-based foods and baby foods for infants and young children as defined by Regulation (EU) No 609/2013 |
0,05 g/kg for solid foods |
||||
Foods for special medical purposes for infants and young children as defined by Regulation (EU) No 609/2013 |
In accordance with the particular nutritional requirements of the infants and young children for whom the products are intended but in any case not higher than the maximum levels specified for the category mentioned in the table corresponding to the products. |
||||
Total diet replacement foods for weight control as defined by Regulation (EU) No 609/2013 |
0,2 g/L (drinks) 1,7 g/kg (bars) |
||||
Foods bearing statements on the absence or reduced presence of gluten in accordance with the requirements of Commission Implementing Regulation (EU) No 828/2014 (2) |
1,25 g/kg |
||||
Unflavoured pasteurised and sterilised (including UHT) milk-based products |
0,05 g/L |
||||
Unflavoured fermented milk-based products, heat treated after fermentation, flavoured fermented milk products including heat-treated products |
0,05 g/L (beverages) 0,4 g/kg (solids) |
||||
Dairy analogues, including beverage whiteners |
0,05 g/L (beverages) 0,25 g/kg (solids) |
||||
Cereal bars |
0,5 g/kg |
||||
Table top sweeteners |
8,3 g/kg |
||||
Fruit and vegetable-based drinks |
0,05 g/L |
||||
Flavoured drinks |
0,05 g/L |
||||
Speciality coffee, tea, herbal and fruit infusions, chicory; tea, herbal and fruit infusions and chicory extracts; tea, plant, fruit and cereal preparations for infusions |
0,2 g/kg |
||||
Food Supplements as defined in Directive 2002/46/EC (3) |
300 mg/day for general population older than 10 years 55 mg/day for infants 130 mg/day for young children 250 mg/day for children between 3 to 10 years of age |
||||
Acheta domesticus (house cricket) partially defatted powder |
Specified food category |
Maximum levels (g/100 g)(marketed as such or reconstituted according to the instructions) |
1. The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Acheta domesticus (house cricket) partially defatted powder’. 2. The labelling of the foodstuffs containing Acheta domesticus (house cricket) partially defatted powder shall bear a statement that this ingredient may cause allergic reactions to consumers with known allergies to crustaceans, molluscs, and products thereof, and to dust mites. This statement shall appear in close proximity to the list of ingredients. |
|
Authorised on 24.1.2023. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: ‘Cricket One Co. Ltd’, 383/3/51 Quang Trung street, Ward 10, Go Vap district, Ho Chi Minh City, Vietnam. During the period of data protection, the novel food Acheta domesticus (house cricket) partially defatted powder is authorised for placing on the market within the Union only by ‘Cricket One Co. Ltd’, unless a subsequent applicant obtains authorisation for that novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283, or with the agreement of ‘Cricket One Co. Ltd’. End date of the data protection: 24.1.2028. |
Multigrain bread and rolls; crackers and breadsticks |
2 |
||||
Cereal bars |
3 |
||||
Pre-mixes for baked products (dry) |
3 |
||||
Biscuits |
1,5 |
||||
Pasta-based products (dry) |
0,25 |
||||
Stuffed pasta-based products (dry) |
3 |
||||
Sauces |
1 |
||||
Processed potato products, legume- and vegetable-based dishes, pizza, pasta-based dishes |
1 |
||||
Whey powder |
3 |
||||
Meat analogues |
5 |
||||
Soups and soup concentrates or powders |
1 |
||||
Maize flour based snacks |
4 |
||||
Beer-like beverages |
0,1 |
||||
Chocolate confectionary |
2 |
||||
Nuts and oilseeds |
2 |
||||
Snacks other than chips |
5 |
||||
Meat preparations |
2 |
||||
|
|||||
Adansonia digitata (Baobab) dried fruit pulp |
Not specified |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Baobab fruit pulp’ |
|
|
|
Frozen, paste, dried and powder forms of Alphitobius diaperinus larvae (lesser mealworm) |
Specified food category |
Maximum levels (g/100g) |
1. The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Frozen/paste Alphitobius diaperinus larvae (lesser mealworm)’ or ‘Dried/powder Alphitobius diaperinus larvae (lesser mealworm)’ depending on the form used. 2. The labelling of food supplements containing the novel food shall bear a statement that those food supplements should not be consumed by persons under 18 years of age. 3. The labelling of the foodstuffs containing frozen, paste, dried or powder forms of Alphitobius diaperinus larvae (lesser mealworm) shall bear a statement that this ingredient may cause allergic reactions to consumers with known allergies to crustaceans, and products thereof, and to dust mites. This statement shall appear in close proximity to the list of ingredients. |
|
Authorised on 26.1.2023. This inclusion is based on proprietary scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: Ynsect NL B.V, Harderwijkerweg 141B, 3852 AB Ermelo, the Netherlands. During the period of data protection, the novel food is authorised for placing on the market within the Union only by Ynsect NL B.V., unless a subsequent applicant obtains authorisation for that novel food without reference to the proprietary scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283, or with the agreement of Ynsect NL B.V. End date of the data protection: 26.1.2028. |
Cereal bars |
25 (Dried form) 25 (Powder form) |
||||
Bread and rolls |
20 (Powder form) |
||||
Processed and breakfast cereals |
10 (Dried form) 10 (Powder form) |
||||
Porridge |
15 (Powder form) |
||||
Pre-mixes (dry) for baked products |
10 (Powder form) |
||||
Dried pasta-based products |
10 (Powder form) |
||||
Stuffed pasta-based products |
28 (Frozen or paste form) 10 (Powder form) |
||||
Whey powder |
35 (Powder form) |
||||
Soups |
15 (Powder form) |
||||
Cereal-, pasta-based dishes |
5 (Powder form) |
||||
Pizza-based dishes |
5 (Dried form) 5 (Powder form) |
||||
Noodles |
10 (Powder form) |
||||
Snacks other than chips |
10 (Dried form) 10 (Powder form) |
||||
Chips/crisps |
10 (Powder form) |
||||
Crackers and bread sticks |
10 (Powder form) |
||||
Peanut butter |
15 (Powder form) |
||||
Ready-to-eat savoury based sandwich |
20 (Powder form) |
||||
Meat preparations |
14 (Frozen or paste form) 5 (Powder form) |
||||
Meat analogues |
40 (Frozen or paste form) 15 (Powder form) |
||||
Milk and dairy analogues |
10 (Powder form) |
||||
Chocolate confectionary |
5 (Powder form) |
||||
Food supplements as defined in Directive 2002/46/EC for the adult population |
4 g/day (Powder form) |
||||
Ajuga reptans extract from cell cultures |
Specified food category |
Maximum levels |
|
|
|
Food Supplements as defined in Directive 2002/46/EC |
In line with normal use in food supplements of a similar extract of the flowering aerial parts of Ajuga reptans |
||||
Akkermansia muciniphila (pasteurised) |
Foods for special medical purposes as defined under Regulation (EU) No 609/2013 for the adult population, excluding pregnant and lactating women |
3,4 × 1010 cells/day |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘pasteurised Akkermansia muciniphila’. |
|
Authorised on 1 March 2022. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: A-Mansia Biotech S.A., rue Granbonpré, 11, Bâtiment H, 1435 Mont-Saint-Guibert. Belgium. During the period of data protection, the novel food pasteurised Akkermansia muciniphila is authorised for placing on the market within the Union only by A-Mansia Biotech S.A., unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Mansia Biotech S.A. End date of the data protection: 1 March 2027. |
Food supplements as defined in Directive 2002/46/EC for the adult population, excluding pregnant and lactating women |
3,4 × 1010 cells/day |
The labelling of food supplements containing pasteurised Akkermansia muciniphila shall bear a statement that they should be consumed by adults only, excluding pregnant and lactating women. |
|||
L-Alanyl-L-Glutamine |
Specified food category |
Maximum levels |
|
|
|
Food Supplements as defined in Directive 2002/46/EC |
|
||||
Foods for special medical purposes as defined in Regulation (EU) No 609/2013 excluding foods for infants and young children |
|||||
Drinks intended to meet the expenditure of intense muscular effort especially for sportsmen |
|||||
Algal oil from the microalgae Ulkenia sp. |
Specified food category |
Maximum levels of DHA |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Oil from the micro-algae Ulkenia sp.’ |
|
|
Bakery products (breads, rolls and sweet biscuits) |
200 mg/100 g |
||||
Cereal bars |
500 mg/100 g |
||||
Non-alcoholic beverages (including milk based beverages) |
60 mg/100 ml |
||||
Allanblackia seed oil |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Allanblackia seed oil’ |
|
|
Yellow fat spreads and cream based spreads |
30 g/100 g |
||||
Mixtures of vegetable oils (*) and milk (falling under the food category: Dairy analogues, including beverage whiteners) |
30 g/100 g |
||||
(*) Except olive oils and olive pomace oils as defined in Part VIII of Annex VII of Regulation (EU) No 1308/2013. |
|||||
Aloe macroclada Baker leaf extract |
Specified food category |
Maximum levels |
|
|
|
Food Supplements as defined in Directive 2002/46/EC |
In line with normal use in food supplements of the similar gel derived from Aloe vera (L.) Burm. |
||||
Antarctic Krill oil from Euphausia superba |
Specified food category |
Maximum levels of combined DHA and EPA |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Lipid extract from the crustacean Antarctic Krill (Euphausia superba)’ |
|
|
Dairy products except milk-based drinks |
200 mg/100 g or for cheese products 600 mg/100 g |
||||
Dairy analogues except drinks |
200 mg/100 g or for analogues to cheese products 600 mg/100 g |
||||
Non-alcoholic beverages Milk-based drinks Dairy analogue drinks |
80 mg/100 ml |
||||
Spreadable fat and dressings |
600 mg/100 g |
||||
Cooking fats |
360 mg/100 ml |
||||
Breakfast cereals |
500 mg/100 g |
||||
Bakery products (breads, rolls and sweet biscuits) |
200 mg/100 g |
||||
Nutrition bars/cereal bars |
500 mg/100 g |
||||
Food Supplements as defined in Directive 2002/46/EC |
3 000 mg/day for the general population 450 mg/day for pregnant and lactating women |
||||
Foods for special medical purposes as defined in Regulation (EU) No 609/2013 |
In accordance with the particular nutritional requirements of the persons for whom the products are intended |
||||
Total diet replacement for weight control as defined in Regulation (EU) No 609/2013 and meal replacements for weight control |
250 mg/meal |
||||
Processed cereal-based food and baby food intended for infants and young children covered by Regulation (EU) No 609/2013 |
200 mg/100 ml |
||||
Foods intended to meet the expenditure of intense muscular effort, especially for sportsmen |
|||||
Foods bearing statements on the absence or reduced presence of gluten in accordance with the requirements of Commission Implementing Regulation (EU) No 828/2014 |
|||||
Antarctic Krill oil rich in phospholipids from Euphausia superba |
Specified food category |
Maximum levels of combined DHA and EPA |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Lipid extract from the crustacean Antarctic Krill (Euphausia superba)’ |
|
|
Dairy products except milk-based drinks |
200 mg/100 g or for cheese products 600 mg/100 g |
||||
Dairy analogues except drinks |
200 mg/100 g or for analogues to cheese products 600 mg/100 g |
||||
Non-alcoholic beverages Milk-based drinks Dairy analogue drinks |
80 mg/100 ml |
||||
Spreadable fat and dressings |
600 mg/100 g |
||||
Cooking fats |
360 mg/100 ml |
||||
Breakfast cereals |
500 mg/100 g |
||||
Bakery products (breads, rolls and sweet biscuits) |
200 mg/100 g |
||||
Nutrition bars/cereal bars |
500 mg/100 g |
||||
Food Supplements as defined in Directive 2002/46/EC |
3 000 mg/day for the general population 450 mg/day for pregnant and lactating women |
||||
Foods for special medical purposes as defined in Regulation (EU) No 609/2013 |
In accordance with the particular nutritional requirements of the persons for whom the products are intended |
||||
Total diet replacement for weight control as defined in Regulation (EU) No 609/2013 and meal replacements for weight control |
250 mg/meal |
||||
Processed cereal-based food and baby food intended for infants and young children covered by Regulation (EU) No 609/2013 |
200 mg/100 ml |
||||
Foods intended to meet the expenditure of intense muscular effort, especially for sportsmen |
|||||
Foods bearing statements on the absence or reduced presence of gluten in accordance with the requirements of Commission Implementing Regulation (EU) No 828/2014 |
|||||
Antrodia camphorata mycelia powder |
Specified food category |
Maximum levels |
1. The designation of the novel food on the labelling of food supplements containing it shall be ‘Antrodia camphorata mycelia powder’. 2. The labelling of the food supplements containing Antrodia camphorata mycelia powder shall bear a statement that this food supplement should not be consumed by infants, children, and adolescents younger than 14 years of age. |
|
|
Food supplements as defined in Directive 2002/46/EC, excluding infants, children, and adolescents younger than 14 years of age |
990 mg/day |
||||
Aqueous ethanolic extract of Labisia pumila |
Specified food category |
Maximum levels |
1. The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘aqueous ethanolic extract of Labisia pumila’. 2. The labelling of food supplements containing the novel food shall bear a statement that they should only be consumed by persons above 18 years of age excluding pregnant and lactating women. |
|
Authorised on 6 June 2023. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: Medika Natura Sdn. Bhd., No. 44B Jalan Bola Tampar 13/14 Section 13, 40100 Shah Alam Selangor, Malaysia. During the period of data protection, the novel food aqueous ethanolic extract of Labisia pumila is authorised for placing on the market within the Union only by Medika Natura Sdn. Bhd., unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Medika Natura Sdn. Bhd. End date of the date protection: 6 June 2028. |
Food supplements as defined in Directive 2002/46/EC for the adult population, excluding pregnant and lactating women |
350 mg/day |
||||
Arachidonic acid-rich oil from the fungus Mortierella alpina |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Oil from Mortierella alpina’ or ‘Mortierella alpina oil’ |
|
|
Infant formula and follow-on formula as defined in Regulation (EU) No 609/2013 |
In accordance with Regulation (EU) No 609/2013 |
||||
Foods for special medical purposes for infants as defined in Regulation (EU) No 609/2013 |
In accordance with Regulation (EU) No 609/2013 |
||||
Argan oil from Argania spinosa |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Argan oil’ and if used as seasoning ‘Vegetable oil only for seasoning’ shall be mentioned on the label |
|
|
As seasonings |
Not specified |
||||
Food Supplements as defined in Directive 2002/46/EC |
In line with normal food use of vegetable oils |
||||
Astaxanthin-rich oleoresin from Haematococcus pluvialis algae |
Specified food category |
Maximum levels of astaxanthin |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Astaxanthin rich oleoresin from Haematococcus pluvialis algae’ The labelling of food supplements containing Astaxanthin rich oleoresin from Haematococcus pluvialis algae shall bear a statement that they should not be consumed: (a) if other food supplements containing astaxanthin esters are consumed on the same day (b) by infants and young children under 3 years of age (c) by infants and children under 10 years of age (12) (d) by infants, children and adolescents under 14 years of age (12). |
|
|
Food supplements as defined in Directive 2002/46/EC excluding infants and young children |
2,3 mg astaxanthin per day for children 3 to less than 10 years of age |
||||
5,7 mg astaxanthin per day for adolescents 10 to less than 14 years of age |
|||||
8 mg astaxanthin per day for general population older than 14 years of age |
|||||
Basil seeds (Ocimum basilicum) |
Specified food category |
Maximum levels |
|
|
|
Fruit juice and fruit/vegetable blend beverages |
3 g/200 ml for addition of whole basil seeds (Ocimum basilicum) |
||||
Betaine |
Specified food category |
Maximum levels (7) |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘betaine’. The labelling of foods containing betaine shall bear a statement that the foods should not be used if food supplements containing betaine are consumed the same day. |
|
Authorised on 22 August 2019. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: DuPont Nutrition Biosciences ApS, Langebrogade 1 Copenhagen K, DK-1411, Denmark. During the period of data protection, the novel food betaine is authorised for placing on the market within the Union only by DuPont Nutrition Biosciences ApS unless a subsequent applicantobtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of DuPont Nutrition Biosciences ApS, End date of the data protection: 22 August 2024. |
Drink powders, isotonic and energy drinks intended for sportsmen |
60 mg/100 g |
||||
Protein and cereal bars intended for sportsmen |
500 mg/100 g |
||||
Meal replacements intended for sportsmen |
20 mg/100 g |
||||
Total diet replacement for weight control as defined under Regulation (EU) No 609/2013 |
500 mg/100 g (bar) 136 mg/100 g (soup) 188 mg/100 g (porridge) 60 mg/100 g (beverages) |
||||
Foods for Special Medical Purposes as defined under Regulation (EU) No 609/2013 for adults |
400 mg/day |
||||
Fermented black bean extract |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Fermented black bean (Soya) extract’’ or ‘Fermented Soya extract’ |
|
|
Food Supplements as defined in Directive 2002/46/EC |
4,5 g/day |
||||
Bovine lactoferrin |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Lactoferrin from cows’ milk’ |
|
|
Infant formula and follow-on formula as defined in Regulation (EU) No 609/2013 (ready to drink) |
100 mg/100 ml |
||||
Foods on dairy basis intended for young children (ready to eat/drink) |
200 mg/100 g |
||||
Processed cereal food (solid) |
670 mg/100 g |
||||
Foods for special medical purposes as defined in Regulation (EU) No 609/2013 |
Depending on the needs of the individual up to 3 g/day |
||||
Beverages based on milk |
200 mg/100 g |
||||
Powdered drink mixes based on milk (ready to drink) |
330 mg/100 g |
||||
Beverages based on fermented milk (including yoghurt drinks) |
50 mg/100 g |
||||
Non-alcoholic drinks |
120 mg/100 g |
||||
Products based on yoghurt |
80 mg/100 g |
||||
Products based on cheese |
2 000 mg/100 g |
||||
Ice cream |
130 mg/100 g |
||||
Cakes and pastries |
1 000 mg/100 g |
||||
Candies |
750 mg/100 g |
||||
Chewing gum |
3 000 mg/100 g |
||||
Bovine milk basic whey protein isolate |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Milk whey protein isolate’. Food supplements containing bovine milk basic whey protein isolate shall bear the following statement: ‘This food supplement should not be consumed by infants/children/adolescents under the age of one/three/eighteen (*) years’ (*) Depending on the age group the food supplement is intended for. |
|
Authorised on 20 November 2018. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: Armor Protéines S.A.S., 19 bis, rue de la Libération 35460 Saint-Brice-en-Coglès, France. During the period of data protection the novel food bovine milk basic whey protein isolate is authorised for placing on the market within the Union only by Armor Protéines S.A.S. unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Armor Protéines S.A.S. End date of the data protection: 20 November 2023. |
Infant formulae as defined in Regulation (EU) No 609/2013 |
30 mg/100 g (powder) |
||||
3,9 mg/100 mL (reconstituted) |
|||||
Follow-on formulae as defined in Regulation (EU) No 609/2013 |
30 mg/100 g (powder) |
||||
4,2 mg/100 mL (reconstituted) |
|||||
Total diet replacement foods for weight control as defined in Regulation (EU) No 609/2013 |
300 mg/day |
||||
Foods for special medical purposes as defined in Regulation (EU) No 609/2013 |
30 mg/100 g (powder formula for infants during the first months of life until the introduction of appropriate complementary feeding) |
||||
3,9 mg/100 mL (reconstituted formula for infants during the first months of life until the introduction of appropriate complementary feeding) |
|||||
30 mg/100 g (powder formula for infants when appropriate complementary feeding is introduced) |
|||||
4,2 mg/100 mL (reconstituted formula for infants when appropriate complementary feeding is introduced) |
|||||
58 mg/day for young children |
|||||
380 mg/day for children and adolescents from 3 to 18 years of age |
|||||
610 mg/day for adults |
|||||
Food supplements as defined in Directive 2002/46/EC |
25 mg/day for infants |
||||
58 mg/day for young children |
|||||
250 mg/day for children and adolescents from 3 to 18 years of age |
|||||
610 mg/day for adults |
|||||
Bovine milk beta-lactoglobulin (β-lactoglobulin) |
Specified food category |
Maximum levels (g NF/100 ml) |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘bovine milk beta-lactoglobulin’ or ‘bovine milk β-lactoglobulin’. |
|
Authorised on 11 January 2023. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: Arla Foods Ingredients Group P/S, Sønderhøj 10-12, 8260 Viby J, Denmark. During the period of data protection, the novel food beta-lactoglobulin (β-lactoglobulin) is authorised for placing on the market within the Union only by Arla Foods Ingredients Group P/S unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Arla Foods Ingredients Group P/S. End date of the data protection: 11 January 2028. |
Soft drinks marketed in relation to physical exercise |
25 |
||||
Whey powder (reconstituted) |
8 |
||||
Milk based drinks and similar products |
12 |
||||
Foods for special medical purposes as defined in Regulation (EU) No 609/2013 intended for the general population older than 3 years of age, excluding pregnant and lactating women |
In accordance with the particular nutritional requirements of the persons for whom the products are intended |
||||
Bovine milk osteopontin |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Bovine milk Osteopontin’. |
|
Authorised on 26 March 2023. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: Arla Foods Ingredients Group P/S., Sønderhøj 10-12 8260 Viby J Denmark. During the period of data protection, the novel food Bovine milk osteopontin is authorised for placing on the market within the Union only by Arla Foods Ingredients Group P/S., unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Arla Foods Ingredients Group P/S. End date of the data protection: 26 March 2028. |
Infant formula as defined in Regulation (EU) No 609/2013 (13) |
151 mg/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Follow-on formula as defined in Regulation (EU) No 609/2013 (13) |
151 mg/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Milk-based drinks intended for young children |
151 mg/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Buglossoides arvensis seed oil |
Specified food category |
Maximum levels of stearidonic acid (STA) |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Refined Buglossoides oil’ |
|
|
Dairy products and analogues |
250 mg/100 g |
||||
75 mg/100 g for drinks |
|||||
Cheese and cheese products |
750 mg/100 g |
||||
Butter and other fat and oil emulsions including spreads (not for cooking or frying purposes) |
750 mg/100 g |
||||
Breakfast cereals |
625 mg/100 g |
||||
Food supplements as defined in Directive 2002/46/EC, excluding food supplements for infants and young children |
500 mg/day |
||||
Foods for special medical purposes as defined in Regulation (EU) No 609/2013, excluding foods for special medical purposes intended for infants and young children |
In accordance with the particular nutritional requirements of the persons for whom the products are intended |
||||
Total diet replacement for weight control as defined in Regulation (EU) No 609/2013 and meal replacements for weight control |
250 mg/meal |
||||
Calanus finmarchicus oil |
Specified food category |
Maximum levels |
1. The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘oil from Calanus finmarchicus (crustacean)’. 2. The labelling of food supplements containing Calanus finmarchicus oil shall bear a statement that those food supplements should not be consumed: a) if other food supplements containing astaxanthin esters are consumed on the same day. b) by infants and children younger than 3 years. c) by children younger than 14 years, if the ingredient contains ≥ 0,1 % astaxanthin. |
|
|
Food supplements as defined in Directive 2002/46/EC, excluding food supplements for infants and young children |
1,0 g/day (< 0,1 % astaxanthin esters, resulting in < 1,0 mg astaxanthin per day) for the general population, excluding infants and young children 2,3 g/day (from 0,1 % to ≤ 0,25 % astaxanthin esters, resulting in ≤ 5,75 mg astaxanthin per day) for the general population older than 14 years of age |
||||
Calcium fructoborate |
Specified food category |
Maximum levels |
1. The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘calcium fructoborate’. 2. The labelling of food supplements containing calcium fructoborate shall bear a statement that those food supplements should not be consumed by population under 18 years of age and by pregnant and lactating women. |
|
Authorised on 23 December 2021. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: VDF FutureCeuticals, Inc., 300 West 6th Street Momence, Illinois 60954, the United States. During the period of data protection, the novel food calcium fructoborate is authorised for placing on the market within the Union only by VDF FutureCeuticals, Inc., unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of VDF FutureCeuticals, Inc. End date of the date protection: 23 December 2026 |
Food supplements as defined in Directive 2002/46/EC for the adult population, excluding food supplements for pregnant and lactating women |
220 mg/day |
||||
Calcium L-Methylfolate |
Specified food category |
Maximum levels (expressed as folic acid) |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Calcium L-Methylfolate’. |
|
|
Foods for special medical purposes and total diet replacement for weight control as defined in Regulation (EU) No 609/2013 |
In accordance with Regulation (EU) No 609/2013 |
||||
Infant formulae and follow-on formula as defined by Regulation (EU) No 609/2013 |
In accordance with Regulation (EU) No 609/2013 |
||||
Processed cereal-based foods and baby foods for infants and young children as defined by Regulation (EU) No 609/2013 |
In accordance with Regulation (EU) No 609/2013 |
||||
Food supplements as defined in Directive 2002/46/EC |
In accordance with Directive 2002/46/EC |
||||
Food fortified in accordance with Regulation (EC) No 1925/2006 |
In accordance with Regulation (EC) No 1925/2006 |
||||
Dried nuts of Canarium ovatum Engl. |
Specified food category |
Maximum levels |
1. The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘nuts of Canarium ovatum’ and/or ‘pilinuts’ and/or ‘pili (Canarium ovatum) nuts’. 2. The labelling of the foodstuffs containing dried nuts of Canarium ovatum Engl. shall bear a statement that the dried nuts of Canarium ovatum Engl. may cause allergic reactions to consumers with known allergies to cashew and walnut. This statement shall appear in close proximity to the list of ingredients or, in the absence of a list of ingredients, in close proximity to the name of the food. |
|
|
Not specified |
|
||||
Canarium indicum L. dried nuts (Kenari) (Traditional food from a third country) |
Specified food category |
Maximum levels (g/100 g) |
1. The designation of the traditional food on the labelling of the foodstuffs containing it shall be ‘dried kenari (Canarium indicum) nuts’. 2. The labelling of the foodstuffs containing dried nuts of Canarium indicum L. shall bear a statement that the nuts may cause allergic reactions to consumers with known allergies to hazel, cashew and pistachio. This statement shall appear in close proximity to the list of ingredients or, in the absence of a list of ingredient, in close proximity to the name of the food. |
|
|
Not specified |
|
||||
Cellobiose |
Specified food category |
Maximum levels |
1. The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘cellobiose’. 2. The labelling of food supplements containing cellobiose shall bear a statement that those food supplements should not be consumed by infants and young children. |
|
Authorised on 1 June 2023. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: SAVANNA Ingredients GmbH, Dürener Straße 67, 50189 Elsdorf, Germany. During the period of data protection, the novel food cellobiose is authorised for placing on the market within the Union only by SAVANNA Ingredients GmbH, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of SAVANNA Ingredients GmbH. End date of the data protection: 1 June 2028. |
Food supplements as defined in Directive 2002/46/EC for the general population, excluding infants and young children |
3 g/day |
||||
Dried, canned-tinned, raw cured (or seasoned), cooked cured (or seasoned) meat |
2 g/100 g |
||||
Fresh raw, preserved or partly preserved sausages |
2 g/100 g |
||||
Meat based spreadable-textured specialties |
2 g/100 g |
||||
Liver based spreadable-textured specialties |
2 g/100 g |
||||
Savoury sauce dry preparation |
40 g/100 g |
||||
Table-top sweeteners in powder form |
60 g/100 g |
||||
Table-top sweeteners in tablets |
60 g/100 g |
||||
Cetylated fatty acids |
Specified food category |
Maximum levels |
1. The designation of the novel food on the labelling of the food supplements containing it shall be ‘cetylated fatty acids preparation’. 2. The labelling of food supplements containing the novel food shall bear a statement that those food supplements should not be consumed by persons under 18 years of age. |
|
Authorised on 3 March 2022. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: Pharmanutra S.p.A., Via Delle Lenze 216/b, 56122 Pisa, Italy. During the period of data protection, the novel food cetylated fatty acids is authorised for placing on the market within the Union only by Pharmanutra S.p.A., unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Pharmanutra S.p.A. End date of the date protection: 3 March 2027 |
Food supplements as defined in Directive 2002/46/EC for the adult population |
1,6 g/day |
||||
Chewing gum base (monomethoxypolyethylene glycol) |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Gum base (including 1,3-butadiene, 2-methyl-homopolymer, maleated, esters with polyethylene glycol mono-Me ether)’ or ‘Gum base (including CAS No: 1246080-53-4)’ |
|
|
Chewing gum |
8 % |
||||
Chewing gum base (Methyl vinyl ether-maleic anhydride copolymer) |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Gum base (including methyl vinyl ether-maleic anhydride copolymer)’ or ‘Gum base (including CAS No 9011-16-9)’ |
|
|
Chewing gum |
2 % |
||||
Chia oil from Salvia hispanica |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Chia oil (Salvia hispanica)’ |
|
|
Fats and oils |
10 % |
||||
Pure chia oil |
2 g/day |
||||
Food Supplements as defined in Directive 2002/46/EC |
2 g/day |
||||
Chia seeds (Salvia hispanica) |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Chia seeds (Salvia hispanica)’ |
|
|
Bread products |
5 % (whole or ground chia seeds) |
||||
Baked products |
10 % whole chia seeds |
||||
Breakfast cereals |
10 % whole chia seeds |
||||
Sterilised ready to eat meals based on cereal grains, pseudocereal grains and/or pulses |
5 % whole chia seeds |
||||
Fruit, nut and seed mixes |
|
||||
Chia seeds as such |
|
||||
Confectionery (including chocolate and chocolate products), excluding chewing gums |
|
||||
Dairy products (including yoghurt) and analogues |
|
||||
Edible ices |
|
||||
Fruit and vegetables products (including fruit spreads, compotes with/without cereals, fruit-preparations to underlay or to be mixed with dairy products, fruit desserts, mixed fruits with coconut milk for a twin pot) |
|
||||
Non-alcoholic beverages (including fruit juice and fruit/vegetable blend beverages) |
|
||||
Puddings that do not require heat treatment at or above 120 °C in their manufacture, processing or preparation |
|
||||
Chitin-glucan from Aspergillus niger |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Chitin-glucan from Aspergillus niger’ |
|
|
Food Supplements as defined in Directive 2002/46/EC |
5 g/day |
||||
Chitin-glucan complex from Fomes fomentarius |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Chitin-glucan from Fomes fomentarius’ |
|
|
Food Supplements as defined in Directive 2002/46/EC |
5 g/day |
||||
Chitosan extract from fungi (Agaricus bisporus; Aspergillus niger) |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Chitosan extract from Agaricus bisporus’ or ‘Chitosan extract from Aspergillus niger’ |
|
|
Food Supplements as defined in Directive 2002/46/EC |
In line with normal use in food supplements of chitosan from crustaceans |
||||
Chondroitin sulphate |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Chondroitin sulphate derived from microbial fermentation and sulphation’ |
|
|
Food supplements as defined in Directive 2002/46/EC for adult population, excluding pregnant and lactating women |
1 200 mg/day |
||||
Chromium Picolinate |
Specified food category |
Maximum levels of total chromium |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Chromium Picolinate’ |
|
|
Foods covered by Regulation (EU) No 609/2013 |
250 μg/day |
||||
Foods fortified in accordance with Regulation (EC) No 1925/2006 (4) |
|||||
Chromium-containing yeast (Yarrowia lipolytica) biomass |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘chromium-containing yeast (Yarrowia lipolytica) biomass’ The labelling of food supplements containing chromium-containing yeast (Yarrowia lipolytica) biomass shall bear a statement that the food supplements should not be consumed by infants and young children (children under 3 years of age)/children from 3 to 9 years of age (12). |
|
|
Food supplements as defined in Directive 2002/46/EC, excluding food supplements for infants and young children |
2 g/day for children from 3 to 9 years of age, resulting in 46 μg of chromium per day 4 g/day for children from 10 years of age, adolescents and adults, resulting in 92 μg of chromium per day |
||||
Cistus incanus L. Pandalis herb |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Cistus incanus L. Pandalis herb’ |
|
|
Herbal infusions |
Intended daily intake: 3 g herbs/day (2 cups/day) |
||||
Citicoline |
Specified food category |
Maximum levels |
1. The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Citicoline’ 2. The labelling of foods containing citicoline shall bear a statement that the product is not intended to be consumed by children |
|
|
Food Supplements as defined in Directive 2002/46/EC |
500 mg/day |
||||
Foods for special medical purposes as defined in Regulation (EU) No 609/2013 |
250 mg per serving and a maximum daily consumption level of 1 000 mg |
||||
Clostridium butyricum |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Clostridium butyricum MIYAIRI 588 (CBM 588)’ or ‘Clostridium butyricum (CBM 588)’ |
|
|
Food Supplements as defined in Directive 2002/46/EC |
1,35 × 108 CFU/day |
||||
Coffea arabica L. and/or Coffea canephora Pierre ex A.Froehner dried cherry pulp and its infusion (Traditional food from a third country) |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘coffee cherry pulp’ and/or ‘cascara (coffee cherry pulp)’, and/or ‘coffee cherry pulp infusion’ and/or ‘coffee cherry pulp dried infusion’. If the product containing the novel food contains more than 150 mg/l of caffeine (as such or after reconstitution), it shall be labelled with the following indication: ‘High caffeine content. Not recommended for children or pregnant or breast-feeding women’ in the same field of vision as the name of the food, followed by the caffeine content expressed in mg per 100 ml. Typical infusion preparations are prepared with up to 6 g of coffee cherry pulp per 100 ml of hot water (> 75 °C). For the coffee cherry pulp placed on the market as such for the preparation of infusions, instructions shall be given to the consumer on the preparation. |
|
|
Coffee cherry pulp from Coffea arabica L. and/or Coffea canephora Pierre ex A.Froehner for the preparation of infusions |
|
||||
Coffee, coffee and chicory extracts, instant coffee, tea, herbal- and fruit-infusions, coffee substitutes, coffee mixes and instant mixes for hot beverages (and their flavoured counterparts). |
|
||||
Flavoured and unflavoured non-alcoholic ready-to-drink beverages |
|
||||
D-ribose |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘D-ribose’. The labelling of foods containing D-ribose shall bear a statement that the foods should not be used if food supplements containing D-ribose are consumed the same day. |
|
Authorised on 16 April 2019. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: Bioenergy Life Science, Inc., 13840 Johnson St. NE, Minneapolis, Minnesota, 55304, USA. During the period of data protection, the novel food D-ribose is authorised for placing on the market within the Union only by Bioenergy Life Science, Inc. unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Bioenergy Life Science, Inc. End date of the data protection: 16 April 2024 (5 years). |
Cereal bars |
0,20 g/100 g |
||||
Fine bakery wares |
0,31 g/100 g |
||||
Chocolate confectionery (excluding chocolate bars) |
0,17 g/100 g |
||||
Milk-based drinks (excluding malts and shakes) |
0,08 g/100 g |
||||
Drinks intended to meet the expenditure of intense muscular effort especially for sportsmen, isotonic and energy drinks |
0,80 g/100 g |
||||
Bars intended to meet the expenditure of intense muscular effort especially for sportsmen |
3,3 g/100 g |
||||
Meal replacement for weight control (as drinks)' |
0,13 g/100 g |
||||
Meal replacement for weight control (as bars) |
3,30 g/100 g |
||||
Confectionery |
0,20 g/100 g |
||||
Tea and infusions (in powder form to be reconstituted) |
0,23 g/100 g |
||||
Extract of defatted cocoa powder |
Specified food category |
Maximum levels |
Consumers shall be instructed not to consume more than 600 mg polyphenols corresponding to 1,1 g of extract of defatted cocoa powder per day |
|
|
Nutrition bars |
1 g/day and 300 mg polyphenols corresponding to not more than 550 mg of extract of defatted cocoa powder in one portion of food (or food supplement) |
||||
Milk based beverages |
|||||
Any other foods (including food supplements as defined in Directive 2002/46/EC) which have become established vehicles for functional ingredients and which are typically positioned for consumption by health conscious adults |
|||||
Low fat cocoa extract |
Specified food category |
Maximum levels |
Consumers shall be instructed not to consume more than 600 mg of cocoa flavanols per day |
|
|
Foods including food supplements as defined in Directive 2002/46/EC |
730 mg per serving and around 1,2 g/day |
||||
Coriander seed oil from Coriandrum sativum |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Coriander seed oil’ |
|
|
Food Supplements as defined in Directive 2002/46/EC |
600 mg/day |
||||
Cranberry extract powder |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘cranberry extract powder’ |
|
Authorised on 20 November 2018. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: Ocean Spray Cranberries Inc. One Ocean Spray Drive Lakeville-Middleboro, MA, 02349, USA. During the period of data protection the novel food, cranberry extract powder, is authorised for placing on the market within the Union only by Ocean Spray Cranberries Inc. unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Ocean Spray Cranberries Inc. End date of the data protection: 20 November 2023. |
Food Supplements as defined in Directive 2002/46/EC for the adult population |
350 mg/day |
||||
Crataegus pinnatifida dried fruit |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Crataegus pinnatifida dried fruit’ |
|
|
Herbal infusions |
In line with normal food use of Crataegus laevigata |
||||
Jams and jellies in accordance with Directive 2001/113/EC (5) |
|||||
Compotes |
|||||
α-cyclodextrin |
Not specified |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Alpha-cyclodextrin’ or ‘α-cyclodextrin’ |
|
|
|
γ-cyclodextrin |
Not specified |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Gamma-Cyclodextrin’ or ‘γ-Cyclodextrin’ |
|
|
|
Decorticated grains of Digitaria exilis (Kippist) Stapf (Traditional food from a third country) |
Not specified |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘decorticated fonio (Digitaria exilis) grains’ |
|
|
|
Dextran preparation produced by Leuconostoc mesenteroides |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Dextran’ |
|
|
Bakery products |
5 % |
||||
Diacylglycerol oil of plant origin |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Diacylglycerol oil of plant origin (at least 80 % diacylglycerols)’ |
|
|
Cooking oils |
|
||||
Fat spreads |
|||||
Salad dressings |
|||||
Mayonnaise |
|||||
Meal replacement for weight control (as drinks) |
|||||
Bakery products |
|||||
Yoghurt type products |
|||||
Dihydrocapsiate (DHC) |
Specified food category |
Maximum levels |
1. The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Dihydrocapsiate’ 2. Food supplements containing synthetic dihydrocapsiate will be labelled as ‘not intended for children up to 4.5 years’ |
|
|
Cereal bars |
9 mg/100 g |
||||
Biscuits, cookies and crackers |
9 mg/100 g |
||||
Rice based snacks |
12 mg/100 g |
||||
Carbonated drinks, dilutable drinks, fruit juice based beverages |
1,5 mg/100 ml |
||||
Vegetable drinks |
2 mg/100 ml |
||||
Coffee based drinks, tea based drinks |
1,5 mg/100 ml |
||||
Flavoured water — still |
1 mg/100 ml |
||||
Precooked oatmeal cereal |
2,5 mg/100 g |
||||
Other cereals |
4,5 mg/100 g |
||||
Ice cream, dairy desserts |
4 mg/100 g |
||||
Pudding mixes (ready to eat) |
2 mg/100 g |
||||
Products based on yoghurt |
2 mg/100 g |
||||
Chocolate confectionery |
7,5 mg/100 g |
||||
Hard candy |
27 mg/100 g |
||||
Sugar-free gum |
115 mg/100 g |
||||
Whitener/creamer |
40 mg/100 g |
||||
Sweeteners |
200 mg/100 g |
||||
Soup (ready to eat) |
1,1 mg/100 g |
||||
Salad dressing |
16 mg/100 g |
||||
Vegetable protein |
5 mg/100 g |
||||
Ready to eat meals |
3 mg/meal |
||||
Meal replacements for weight control |
3 mg/meal |
||||
Meal replacement for weight control (as drinks) |
1 mg/100 ml |
||||
Food Supplements as defined in Directive 2002/46/EC |
3 mg/single intake 9 mg/day |
||||
Non-alcoholic powdered drink mixes |
14,5 mg/kg equivalent to 1,5 mg/100 ml |
||||
Dried Euglena gracilis |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘dried biomass of Euglena gracilis algae’. The labelling of food supplements containing dried Euglena gracilis shall bear a statement that those food supplements should not be consumed by infants/children under 3 years of age/children under 10 years of age/children and adolescents under 18 years of age (12). |
|
Authorised on 23 December 2020. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: Kemin Foods L.C., 2100 Maury Street Des Moines, IA 50317, USA. During the period of data protection, the novel food is authorised for placing on the market within the Union only by Kemin Foods L.C. unless a subsequent applicant obtains authorisation for that novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Kemin Foods L.C. End date of the data protection: 23 December 2025. |
Breakfast cereal bars, granola bars and protein bars |
630 mg/100 g |
||||
Yoghurt |
150 mg/100 g |
||||
Yoghurt Beverages |
95 mg/100 g |
||||
Fruit and vegetable juices, nectars, fruit/vegetable blend beverages |
120 mg/100 g |
||||
Fruit-Flavoured Drinks |
40 mg/100 g |
||||
Meal replacement beverages |
75 mg/100 g |
||||
Food supplements as defined in Directive 2002/46/EC, excluding food supplements for infants |
100 mg/day for young children 150 mg/day for children from 3 to 9 years of age 225 mg/day for children from 10 years of age and adolescents (to 17 years of age) 375 mg/day for adults |
||||
Total diet replacement for weight control as defined by Regulation (EU) No 609/2013 |
190 mg/meal |
||||
Dried aerial parts of Hoodia parviflora |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘dried aerial parts of Hoodia parviflora’ |
|
Authorised on 3 September 2018. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: Desert Labs, Ltd Kibbutz Yotvata, 88820 Israel. During the period of data protection the novel food dried aerial parts of Hoodia parviflora is authorised for placing on the market within the Union only by Desert Labs, Ltd unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Desert Labs, Ltd. End date of the data protection: 3 September 2023. |
Food Supplements as defined in Directive 2002/46/EC for adult population |
9,4 mg/day |
||||
Dried extract of Lippia citriodora from cell cultures |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘dried extract of Lippia citriodora from cell cultures HTN®Vb’ |
|
|
Food Supplements as defined in Directive 2002/46/EC |
In line with normal use in food supplements of a similar extract from the leaves of Lippia citriodora |
||||
Echinacea angustifolia extract from cell cultures |
Specified food category |
Maximum levels |
|
|
|
Food Supplements as defined in Directive 2002/46/EC |
In line with normal use in food supplements of a similar extract from the root of Echinacea angustifolia |
||||
Echinacea purpurea extract from cell cultures |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘dried extract of Echinacea purpurea from cell cultures EchiPure-PC™’ |
|
|
Food Supplements as defined in Directive 2002/46/EC |
In line with normal use in food supplements of a similar extract from florets within the flower head of Echinacea purpurea |
||||
Echium plantagineum oil |
Specified food category |
Maximum levels of stearidonic acid (STA) |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Refined echium oil’ |
|
|
Milk-based products and drinkable yoghurt products delivered in a single dose |
250 mg/100 g; 75 mg/100 g for drinks |
||||
Cheese preparations |
750 mg/100 g |
||||
Spreadable fat and dressings |
750 mg/100 g |
||||
Breakfast cereals |
625 mg/100 g |
||||
Food supplements as defined in Directive 2002/46/EC |
500 mg/day |
||||
Foods for special medical purposes as defined in Regulation (EU) No 609/2013 |
In accordance with the particular nutritional requirements of the persons for whom the products are intended |
||||
Total diet replacement for weight control as defined in Regulation (EU) No 609/2013 and meal replacements for weight control |
250 mg/meal |
||||
Ecklonia cava phlorotannins |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Ecklonia cava Phlorotannins’. Food supplements containing Ecklonia cava phlorotannins shall bear the following statement: (a) This food supplement should not be consumed by children/adolescents under the age of twelve/fourteen/eighteen(*) years. (b) This food supplement should not be consumed by persons with thyroid disease or by persons who are aware of or have been identified as being at risk of developing thyroid disease. (c) This food supplement should not be consumed if other food supplements containing iodine are also consumed. (*) Depending on the age group the food supplement is intended for. |
|
|
Food supplements as defined in Directive 2002/46/EC intended for the general population, excluding children under the age of 12 years |
163 mg/day for adolescents from 12 to 14 years of age 230 mg/day for adolescents above 14 years of age 263 mg/day for adults |
||||
Egg membrane hydrolysate |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘egg membrane hydrolysate’. |
|
Authorised on 25 November 2018. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: Biova, LLC., 5800 Merle Hay Rd, Suite 14 PO Box 394 Johnston 50131, Iowa USA. During the period of data protection the novel food egg membrane hydrolysate is authorised for placing on the market within the Union only by Biova, LLC. unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Biova, LLC. End date of the data protection: 25 November 2023 |
Food Supplements as defined in Directive 2002/46/EC intended for the general adult population |
450 mg/day |
||||
Epigallocatechin gallate as a purified extract from green tea leaves (Camellia sinensis) |
Specified food category |
Maximum levels |
The labelling shall bear a statement that consumers should not consume more than 300 mg of extract per day |
|
|
Foods including food supplements as defined in Directive 2002/46/EC |
150 mg of extract in one portion of food or food supplement |
||||
L-ergothioneine |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘L-ergothioneine’ |
|
|
Alcohol-free beverages |
0,025 g/kg |
||||
Milk-based drinks |
0,025 g/kg |
||||
‘Fresh’ milk products(*) |
0,040 g/kg |
||||
Cereal bars |
0,2 g/kg |
||||
Chocolate confectionery |
0,25 g/kg |
||||
Food supplements as defined in Directive 2002/46/EC |
30 mg/day for general population (excluding pregnant and lactating women) 20 mg/day for children older than 3 years |
||||
(*) When used in milk products L-ergothioneine may not replace in whole or in part, any milk constituent |
|||||
Roasted and popped kernels from the seeds of Euryale ferox Salisb. (makhana) (Traditional food from a third country) |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘roasted seeds of Euryale ferox’ or ‘makhana (Euryale ferox) roasted seeds’ |
|
|
Processed nuts |
|
||||
Extract of three herbal roots (Cynanchum wilfordii Hemsley, Phlomis umbrosa Turcz. and Angelica gigas Nakai) |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘extract of three herbal roots (Cynanchum wilfordii Hemsley, Phlomis umbrosa Turcz. and Angelica gigas Nakai)’. The labelling of food supplements containing the extract of mixture of the three herbal roots shall bear a statement in close proximity to the list of ingredients indicating that it should not be consumed by individuals with known celery allergy. |
|
|
Food supplements as defined in Directive 2002/46/EC for adult population |
175 mg/day |
||||
Ferric Sodium EDTA |
Specified food category |
Maximum levels (expressed as anhydrous EDTA) |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Ferric Sodium EDTA’ |
|
|
Food supplements as defined in Directive 2002/46/EC |
18 mg/day for children 75 mg/day for adults |
||||
Foods covered by Regulation (EU) No 609/2013 |
12 mg/100 g |
||||
Foods fortified in accordance with Regulation (EC) No 1925/2006 |
|||||
Ferrous ammonium phosphate |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Ferrous ammonium phosphate’ |
|
|
Food supplements as defined in Directive 2002/46/EC |
To be used in compliance with Directive 2002/46/EC, Regulation (EU) No 609/2013 and/or Regulation (EC) No 1925/2006 |
||||
Foods covered by Regulation (EU) No 609/2013 |
|||||
Foods fortified in accordance with Regulation (EC) No 1925/2006 |
|||||
Fish peptides from Sardinops sagax |
Specified food category |
Maximum levels fish peptide product |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Fish (Sardinops sagax) peptides’ |
|
|
Foods based on yoghurt, yoghurt drinks, fermented milk products, and powdered milk |
0,48 g/100 g (ready to eat/drink) |
||||
Flavoured water, and vegetable-based drinks |
0,3 g/100 g (ready to drink) |
||||
Breakfast cereals |
2 g/100 g |
||||
Soups, stews and soup powders |
0,3 g/100 g (ready to eat) |
||||
Flavonoids from Glycyrrhiza glabra |
Specified food category |
Maximum levels of flavonoids from Glycyrrhiza glabra |
1. The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Flavonoids from Glycyrrhiza glabra L.’ 2. The labelling of the foods where the product was added as a novel food ingredient shall bear a statement that: (a) the product should not be consumed by pregnant and breast feeding women, children and young adolescents; and (b) people taking prescription drugs should only consume the product under medical supervision; (c) a maximum of 120 mg of flavonoids per day should be consumed. 3. The amount of flavonoids in the final food shall be indicated on the labelling of the food containing it. |
Beverages containing flavonoids shall be presented to the final consumer as single portions. |
|
Beverages based on milk |
120 mg/day |
||||
Beverages based on yoghurt |
|||||
Beverages based on fruit or vegetables |
|||||
Food Supplements as defined in Directive 2002/46/EC |
120 mg/day |
||||
Total diet replacement for weight control as defined in Regulation (EU) No 609/2013 |
120 mg/day |
||||
Foods for special medical purposes as defined in Regulation (EU) No 609/2013 |
120 mg/day |
||||
Fruit pulp, pulp juice, concentrated pulp juice from Theobroma cacao L. (Traditional food from a third country) |
Not specified |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘cocoa (Theobroma cacao L.) pulp’, ‘cocoa (Theobroma cacao L.) pulp juice’ or ‘cocoa (Theobroma cacao L.) concentrated pulp juice’ depending on the form used. |
|
|
|
Fucoidan extract from the seaweed Fucus vesiculosus |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Fucoidan extract from seaweed Fucus vesiculosus’. |
|
|
Foods including food supplements as defined in Directive 2002/46/EC for the general population |
250 mg/day |
||||
Fucoidan extract from the seaweed Undaria pinnatifida |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Fucoidan extract from seaweed Undaria pinnatifida’ |
|
|
Foods including food supplements as defined in Directive 2002/46/EC for the general population |
250 mg/day |
||||
2’-Fucosyllactose |
Specified food category |
Maximum levels |
1. The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘2′-fucosyllactose’. 2. The labelling of food supplements containing 2′-fucosyllactose shall bear a statement that the supplements should not be used if other foods with added 2′-fucosyllactose are consumed the same day. 3. The labelling of food supplements containing 2′-fucosyllactose intended for young children shall bear a statement that the supplements should not be used if breast milk or other foods with added 2′-fucosyllactose are consumed the same day. |
|
|
Unflavoured pasteurised and sterilised (including UHT) milk-based products |
1,2 g/l |
||||
Unflavoured fermented milk-based products |
1,2 g/l for beverages |
||||
19,2 g/kg for products other than beverages |
|||||
Flavoured fermented milk-based products including heat-treated products |
1,2 g/l for beverages |
||||
19,2 g/kg for products other than beverages |
|||||
Dairy analogues, including beverage whiteners |
1,2 g/l for beverages |
||||
12 g/kg for products other than beverages |
|||||
400 g/kg for whitener |
|||||
Cereal bars |
12 g/kg |
||||
Table-top sweeteners |
200 g/kg |
||||
Infant formula as defined under Regulation (EU) No 609/2013 |
1,2 g/l in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Follow-on formula as defined under Regulation (EU) No 609/2013 |
1,2 g/l in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Processed cereal-based foods and baby foods for infants and young children as defined under Regulation (EU) No 609/2013 |
12 g/kg for products other than beverages |
||||
1,2 g/l for liquid food ready for use, marketed as such or reconstituted as instructed by the manufacturer |
|||||
Milk based drinks and similar products intended for young children |
1,2 g/l for milk-based drinks and similar products in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Foods for special medical purposes as defined under Regulation (EU) No 609/2013 |
In accordance with the particular nutritional requirements of the persons for whom the products are intended |
||||
Total diet replacement for weight control as defined in Regulation (EU) No 609/2013 |
4,8 g/l for drinks |
||||
40 g/kg for bars |
|||||
Bread and pasta products bearing statements on the absence or reduced presence of gluten in accordance with the requirements of Implementing Regulation (EU) No 828/2014 |
60 g/kg |
||||
Flavoured drinks |
1,2 g/l |
||||
Coffee, tea (excluding black tea), herbal and fruit infusions, chicory; tea, herbal and fruit infusions and chicory extracts; tea, plant, fruit and cereal preparations for infusions, as well as mixes and instant mixes of these products |
9,6 g/l – the maximum level refers to the products ready to use |
||||
Food supplements as defined in Directive 2002/46/EC, for the general population, excluding infants |
3,0 g/day for general population |
||||
1,2 g/day for young children |
|||||
2'-Fucosyllactose/Difucosyllactose mixture (‘2'-FL/DFL’) (microbial source) |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘2'-Fucosyllactose/Difucosyllactose mixture’. The labelling of food supplements containing the 2'-Fucosyllactose/Difucosyllactose mixture shall bear a statement that they should not be used if breast milk or other foods containing added 2'-Fucosyllactose and/or Difucosyllactose are consumed the same day. |
|
Authorised on 19.12.2019. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: Glycom A/S, Kogle Allé 4, DK-2970 Hørsholm, Denmark. During the period of data protection, the novel food 2'-Fucosyllactose/Difucosyllactose mixture is authorised for placing on the market within the Union only by Glycom A/S, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Glycom A/S. End date of the data protection: 19.12.2024. |
Unflavoured pasteurised and unflavoured sterilised (including UHT) milk products |
2,0 g/L |
||||
Unflavoured fermented milk-based products |
2,0 g/L (beverages) 20 g/kg (products other than beverages) |
||||
Flavoured fermented milk-based products including heat-treated products |
2,0 g/L (beverages) 20 g/kg (products other than beverages) |
||||
Beverages (flavoured drinks) |
2,0 g/L |
||||
Cereal bars |
20 g/kg |
||||
Infant formula as defined under Regulation (EU) No 609/2013 |
1,6 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Follow-on formula as defined under Regulation (EU) No 609/2013 |
1,2 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Processed cereal-based food and baby food for infants and young children as defined under Regulation (EU) No 609/2013 |
1,2 g/L (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer 10 g/kg for products other than beverages |
||||
Total diet replacement foods for weight control as defined under Regulation (EU) No 609/2013 |
4,0 g/L (beverages) 40 g/kg (products other than beverages) |
||||
Food for special medical purposes as defined under Regulation (EU) No 609/2013 |
In accordance with the particular nutritional requirements of the persons for whom the products are intended |
||||
Food Supplements as defined in Directive 2002/46/EC intended for the general population excluding infants |
4,0 g/day |
||||
Milk-based drinks and similar products intended for young children |
1,2 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
3-Fucosyllactose (3-FL) (microbial source) |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘3-Fucosyllactose’. The labelling of food supplements containing 3-Fucosyllactose (3-FL) shall bear a statement that they should not be consumed: a) if foods containing added 3-Fucosyllactose are consumed on the same day; b) by infants and children under 3 years of age. |
|
Authorised on 12 December 2021. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: DuPont Nutrition & Biosciences ApS Langebrogade 1, 1001 Copenhagen K, Denmark. During the period of data protection, the novel food 3-Fucosyllactose is authorised for placing on the market within the Union only by DuPont Nutrition & Biosciences ApS, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of DuPont Nutrition & Biosciences ApS. End date of the data protection: 12 December 2026. |
Unflavoured pasteurised and unflavoured sterilised (including UHT) milk products |
0,85 g/L |
||||
Unflavoured and flavoured fermented milk-based products including heat-treated products |
0,5 g/L (beverages) |
||||
5,0 g/kg (products other than beverages) |
|||||
Dairy analogues |
0,85 g/L (beverages) |
||||
8,5 g/kg (products other than beverages) |
|||||
Flavoured drinks, energy and sports drinks |
1,0 g/L |
||||
Cereal bars |
30,0 g/kg |
||||
Infant formula as defined under Regulation (EU) No 609/2013 |
0,85 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Follow-on formula as defined under Regulation (EU) No 609/2013 |
0,85 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Milk-based drinks and similar products intended for young children |
0,85 g/L (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Processed cereal-based food and baby food for infants and young children as defined under Regulation (EU) No 609/2013 |
0,3 g/L (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
3,0 g/kg for products other than beverages |
|||||
Total diet replacement foods for weight control as defined under Regulation (EU) No 609/2013 |
2,0 g/L (beverages) |
||||
30,0 g/kg (products other than beverages) |
|||||
Foods for special medical purposes as defined under Regulation (EU) No 609/2013 |
In accordance with the particular nutritional requirements of the persons for whom the products are intended |
||||
Food Supplements as defined in Directive 2002/46/EC, excluding food supplements for infants and young children |
5,0 g/day |
||||
3-Fucosyllactose (‘3-FL’) (produced by a derivative strain of E. coli BL21(DE3)) |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘3-fucosyllactose’. The labelling of food supplements containing 3-Fucosyllactose (3-FL) shall bear a statement that (a) they should not be consumed by children under 3 years of age; (b) they should not be used if other foods containing added 3-Fucosyllactose are consumed on the same day. |
|
Authorised on 25.1.2023. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: ‘Chr. Hansen A/S’, Bøge Allé 10-12, 2970 Hørsholm, Denmark. During the period of data protection, the novel food 3-Fucosyllactose is authorised for placing on the market within the Union only by Chr. Hansen A/S unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of ‘Chr. Hansen A/S’. End date of the data protection: 25.1.2028. |
Infant formula as defined under Regulation (EU) No 609/2013 |
0,90 g/l in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Follow-on formula as defined under Regulation (EU) No 609/2013 |
1,20 g/l in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Processed cereal-based foods for infants and young children and baby foods for infants and young children as defined under Regulation (EU) No 609/2013 |
1,20 g/l or 1,20 g/kg in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Milk based drinks and similar products intended for young children |
1,20 g/l in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Foods for special medical purposes for infants and young children as defined under Regulation (EU) No 609/2013 |
In accordance with the particular nutritional requirements of the infants and young children for whom the products are intended but in any case not higher than 0,9 g/l or 0,9 g/kg (if it is intended for infants from 0 until 6 months) and 1,2 g/l or 1,2 g/kg (if it is intended for infants of 6-12 months and/or for young children) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer. |
||||
Foods for special medical purposes as defined under Regulation (EU) No 609/2013 excluding foods for infants and young children |
In accordance with the particular nutritional requirements of the persons for whom the products are intended |
||||
Food Supplements as defined in Directive 2002/46/EC, for the general population, excluding infants and young children |
3 g/day |
||||
Galacto-oligosaccharide |
Specified food category |
Maximum levels (expressed as ratio kg galacto-oligosaccharide/kg final food) |
|
|
|
Food supplements as defined in Directive 2002/46/EC |
0,333 |
||||
Food supplements as defined in Directive 2002/46/EC, excluding infants and young children |
0,450 (corresponding to 5,4 g galacto-oligosaccharide/serving; maximum 3 servings/day up to a maximum of 16,2 g/day) |
||||
Foods for special medical purposes as defined by Regulation (EU) No 609/2013, excluding infants and young children |
In accordance with the particular nutritional requirements of the persons for whom the products are intended but not more than 0,128 (corresponding to a maximum of 8,25 g galacto-oligosaccharide/day) |
||||
Milk |
0,020 |
||||
Milk drinks |
0,030 |
||||
Meal replacement for weight control (as drinks) |
0,020 |
||||
Dairy analogue drinks |
0,020 |
||||
Yoghurt |
0,033 |
||||
Dairy based desserts |
0,043 |
||||
Frozen dairy desserts |
0,043 |
||||
Fruit drinks and energy drinks |
0,021 |
||||
Infant meal replacement drinks |
0,012 |
||||
Baby juice |
0,025 |
||||
Baby yogurt drink |
0,024 |
||||
Baby dessert |
0,027 |
||||
Baby snack |
0,143 |
||||
Baby cereals |
0,027 |
||||
Drinks intended to meet the expenditure of intense muscular effort especially for sportsmen |
0,013 |
||||
Juice |
0,021 |
||||
Fruit pie filling |
0,059 |
||||
Fruit preparations |
0,125 |
||||
Bars |
0,125 |
||||
Cereals |
0,125 |
||||
Infant formula and follow-on formula as defined in Regulation (EU) No 609/2013 |
0,008 |
||||
Dairy confectionery |
0,05 |
||||
Cheese and processed cheese |
0,1 |
||||
Butter and spreadable fats |
0,1 |
||||
Glucosamine HCl |
Specified food category |
Maximum levels |
|
|
|
Food Supplements as defined in Directive 2002/46/EC |
In line with normal food use of glucosamine from shell fish |
||||
Foods covered by Regulation (EU) No 609/2013 |
|||||
|
|||||
Meal replacement for weight control |
|||||
Foods intended to meet the expenditure of intense muscular effort, especially for sportsmen |
|||||
Foods bearing statements on the absence or reduced presence of gluten in accordance with the requirements of Commission Implementing Regulation (EU) No 828/2014 |
|||||
Glucosamine sulphate KCl |
Specified food category |
Maximum levels |
|
|
|
Food Supplements as defined in Directive 2002/46/EC |
In line with normal food use of glucosamine from shell fish |
||||
Glucosamine sulphate NaCl |
Specified food category |
Maximum levels |
|
|
|
Food Supplements as defined in Directive 2002/46/EC |
In line with normal food use of glucosamine from shell fish |
||||
Guar Gum |
Specified food category |
Maximum levels |
1. The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Guar Gum’. 2. A specific mention of the possible risks of digestive discomfort linked to the exposure of children aged under 8 to guar gum must be visible on the label of any foodstuffs containing it. For example, ‘Excessive consumption of these products may cause digestive discomfort, especially for children under 8 years of age’. 3. In the case of products with two compartments containing dairy and cereal products respectively, the instructions for use must clearly specify the need to mix the cereal and the dairy product before consumption, in order to take into account the potential risk of gastro-intestinal obstruction. |
|
|
Fresh dairy products such as yogurts, fermented milks, fresh cheeses and other dairy-based desserts. |
1,5 g/100 g |
||||
Fruit or vegetable-based liquid foodstuffs (of the ‘smoothie’ variety) |
1,8 g/100 g |
||||
Fruit or vegetable-based compotes |
3,25 g/100 g |
||||
Cereals accompanied by a dairy product, in packaging containing two compartments |
10 g/100 g in the cereals None in the accompanying dairy product 1 g/100 g in the product when ready to eat |
||||
Heat-treated milk products fermented with Bacteroides xylanisolvens |
Specified food category |
Maximum levels |
|
|
|
Fermented milk products (in liquid, semi-liquid and spray-dried powder forms) |
|
||||
Hydroxytyrosol |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the food products containing it shall be ‘hydroxytyrosol’. The labelling of the food products containing hydroxytyrosol shall bear the following statements: (a) This food product should not be consumed by children under the age of three years, pregnant women, and lactating women; (b) This food product should not be used for cooking, baking or frying’ |
|
|
Fish and vegetable oils, (except olive oils and olive pomace oils as defined in Part VIII of Annex VII of Regulation (EU) No 1308/2013 (6)), placed as such on the market |
0,215 g/kg |
||||
Spreadable fats as defined in Part VII of Annex VII of Regulation (EU) No 1308/2013, placed as such on the market |
0,175 g/kg |
||||
Ice Structuring Protein type III HPLC 12 |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Ice Structuring Protein’ |
|
|
Edible ices |
0,01 % |
||||
Aqueous extracts of dried leaves of Ilex guayusa |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Extracts of dried leaves of Ilex guayusa’ |
|
|
Herbal infusions |
In line with normal use in herbal infusions and food supplements of a similar aqueous extract of dried leaves of Ilex paraguariensis |
||||
Food Supplements as defined in Directive 2002/46/EC |
|||||
Infusion from coffee leaves of Coffea arabica L. and/or Coffea canephora Pierre ex A. Froehner (Traditional food from a third country) |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Infusion from coffee leaves’ or ‘Dried infusion from coffee leaves’, depending on the form to be marketed. |
|
|
Infusion from coffee leaves of Coffea arabica L. and/or Coffea canephora Pierre ex A. Froehner placed on the market as such |
|
||||
Flavoured and unflavoured non-alcoholic ready-to-drink beverages (14) |
|
||||
Coffee, coffee and chicory extracts, instant coffee, tea, herbal- and fruit-infusions, coffee substitutes, coffee mixes and instant mixes for beverages (and their flavoured counterparts) (14) |
|
||||
Iron hydroxide adipate tartrate |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘iron hydroxide adipate tartrate (nano)’. The labelling of food supplements containing iron hydroxide adipate tartrate shall bear a statement that they should not be consumed by children and adolescents under the age of 18/children under 4 years of age (*) (*) Depending on the age group the food supplement is intended for. |
|
Authorised on 28.8.2022. This inclusion is based on proprietary scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: Nemysis Limited, Suite 4.01 Ormond Building 31-36 Ormond Quay Upper Arran Quay Dublin 7, D07 F6DC, Dublin, Ireland. During the period of data protection, the novel food iron hydroxide adipate tartrate is authorised for placing on the market within the Union only by Nemysis Limited, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Nemysis Limited. End date of the data protection: 28.8.2027. |
Food supplements as defined in Directive 2002/46/EC for the adult population |
≤ 100 mg/day (≤ 30 mg Fe/day) |
||||
Food supplements as defined in Directive 2002/46/EC for children and adolescents under 18 years of age, excluding children under 4 years of age |
≤ 50 mg/day (≤ 14 mg Fe/day) |
||||
Iron milk caseinate |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘iron milk caseinate’. The labelling of food supplements containing iron milk caseinate shall bear a statement that (a) they should not be consumed by children under 3 years of age; (b) they should not be consumed if other foods containing iron milk caseinate and/or if other foods with added iron are consumed the same day. |
|
Authorised on 4 June 2023. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: ‘Société des Produits Nestlé S.A.’, Avenue Nestlé 55, 1800 Vevey, Switzerland. During the period of data protection, the iron milk caseinate is authorised for placing on the market within the Union only by ‘Société des Produits Nestlé S.A.’ unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of ‘Société des Produits Nestlé S.A.’. End date of the data protection: 4 June 2028. |
Milk and dairy powder products |
500 mg/100 g (≤ 10 mg Fe/100 g) |
||||
Soft-drinks marketed in relation to physical exercise |
85 mg/100 g (≤ 1,7 mg Fe/100 g) |
||||
Powder cocoa beverage preparations |
400 mg/100 g (≤ 8 mg Fe/100 g) |
||||
Powder or liquid malt-based coffee substitutes |
1 050 mg/100 g (≤ 21 mg Fe/100 g) |
||||
Cereal bars |
350 mg/100 g (≤ 7 mg Fe/100 g) |
||||
|
|
||||
Noodles other than glass noodles |
75 mg/100 g (≤ 1,5 mg Fe/100 g) |
||||
Stock cubes or granulates (bouillon base) |
4 750 mg/100 g (≤ 95 mg Fe/100 g) |
||||
Single meal replacements for weight control |
120 mg/100 g (≤ 2,4 mg Fe/100 g) |
||||
Total diet replacement for weight control as defined under Regulation (EU) No 609/2013 |
235 mg/meal (≤ 4,7 mg Fe/meal) or 700 mg/day (≤ 14,0 mg/Fe/day) |
||||
Foods for special medical purposes as defined under Regulation (EU) No 609/2013 excluding foods for infants and young children |
In accordance with the particular nutritional requirements of the persons for whom the products are intended |
||||
Food supplements as defined in Directive 2002/46/EC, for the adult population |
700 mg/day (≤ 14 mg Fe/day) |
||||
Food supplements as defined in Directive 2002/46/EC, for children and adolescents under 18 years of age, excluding infants and young children |
350 mg/day (≤ 7 mg Fe/day) |
||||
Isomalto-oligosaccharide |
Specified food category |
Maximum levels |
1. The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Isomaltooligosaccharide’. 2. Foods containing the novel ingredient must be labelled as ‘a source of glucose’. |
|
|
Energy-Reduced Soft Drinks |
6,5 % |
||||
Energy Drinks |
5,0 % |
||||
Foods intended to meet the expenditure of intense muscular efforts, especially for sportsmen (including isotonic drinks) |
6,5 % |
||||
Fruit Juices |
5 % |
||||
Processed Vegetables and Vegetable Juices |
5 % |
||||
Other Soft Drinks |
5 % |
||||
Cereals Bars |
10 % |
||||
Cookies, Biscuits |
20 % |
||||
Breakfast Cereal Bars |
25 % |
||||
Hard Candies |
97 % |
||||
Soft Candies/Chocolate Bars |
25 % |
||||
Meal replacement for weight control (as bars or milk based) |
20 % |
||||
Isomaltulose |
Not specified |
1. The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Isomaltulose’. 2. The designation of the novel food on the labelling shall be accompanied by indication that the ‘Isomaltulose is a source of glucose and fructose’. |
|
|
|
Jatropha curcas L. (edible variety) kernels |
Specified food category |
Maximum levels (g/100g) |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘kernels from edible Jatropha curcas L.’ |
|
Authorised on 12 July 2022. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: ‘JatroSolutions GmbH’, Echterdinger Strasse 30, 70599 Stuttgart, Germany. During the period of data protection, the novel food kernels from the edible variety of Jatropha curcas L. is authorised for placing on the market within the Union only by ‘JatroSolutions GmbH’, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of ‘JatroSolutions GmbH’. End date of the data protection: 12 July 2027. |
Kernels as such, candied or sugar preserved and as processed nuts |
|
||||
Cereal bars |
5 |
||||
Breakfast cereals |
5 |
||||
Dried fruits |
5 |
||||
|
|||||
Lactitol |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the food supplements containing it shall be ‘Lactitol’ |
|
|
Food Supplements as defined in Directive 2002/46/EC (capsules, tablets or powder) intended for the adult population |
20 g/day |
||||
Lacto-N-neotetraose |
Specified food category |
Maximum levels |
1. The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘lacto-N-neotetraose’. 2. The labelling of food supplements containing lacto-N-neotetraose shall bear a statement that the supplements should not be used if other foods with added lacto-N-neotetraose are consumed the same day. 3. The labelling of food supplements containing lacto-N-neotetraose intended for young children shall bear a statement that the supplements should not be used if breast milk or other foods with added lacto-N-neotetraose are consumed the same day. |
|
|
Unflavoured pasteurised and sterilised (including UHT) milk-based products |
0,6 g/l |
||||
Unflavoured fermented milk-based products |
0,6 g/l for beverages |
||||
9,6 g/kg for products other than beverages |
|||||
Flavoured fermented milk-based products including heat-treated products |
0,6 g/l for beverages |
||||
9,6 g/kg for products other than beverages |
|||||
Dairy analogues, including beverage whiteners |
0,6 g/l for beverages |
||||
6 g/kg for products other than beverages |
|||||
200 g/kg for whitener |
|||||
Cereal bars |
6 g/kg |
||||
Table-top sweeteners |
100 g/kg |
||||
Infant formula as defined under Regulation (EU) No 609/2013 |
0,6 g/l in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Follow-on formula as defined under Regulation (EU) No 609/2013 |
0,6 g/l in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Processed cereal-based foods and baby foods for infants and young children as defined under Regulation (EU) No 609/2013 |
6 g/kg for products other than beverages |
||||
0,6 g/l for liquid food ready for use, marketed as such or reconstituted as instructed by the manufacturer |
|||||
Milk based drinks and similar products intended for young children |
0,6 g/l for milk-based drinks and similar products in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Foods for special medical purposes as defined under Regulation (EU) No 609/2013 |
In accordance with the particular nutritional requirements of the persons for whom the products are intended |
||||
Total diet replacement for weight control as defined in Regulation (EU) No 609/2013 |
2,4 g/l for drinks |
||||
20 g/kg for bars |
|||||
Bread and pasta products bearing statements on the absence or reduced presence of gluten in accordance with the requirements of Commission Implementing Regulation (EU) No 828/2014 |
30 g/kg |
||||
Flavoured drinks |
0,6 g/l |
||||
Coffee, tea (excluding black tea), herbal and fruit infusions, chicory; tea, herbal and fruit infusions and chicory extracts; tea, plant, fruit and cereal preparations for infusions, as well as mixes and instant mixes of these products |
4,8 g/l – the maximum level refers to the products ready to use |
||||
Food Supplements as defined in Directive 2002/46/EC, for the general population, excluding infants |
1,5 g/day for general population 0,6 g/day for young children |
||||
Lacto-N-tetraose (‘LNT’) (microbial source) |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘lacto-N-tetraose’. The labelling of food supplements containing lacto-N-tetraose shall bear a statement that they should not be used if breast milk or other foods containing added lacto-N-tetraose are consumed the same day. |
|
Authorised on 23.4.2020. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: Glycom A/S, Kogle Allé 4, DK-2970 Hørsholm, Denmark. During the period of data protection, the novel food lacto-N-tetraose is authorised for placing on the market within the Union only by Glycom A/S, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Glycom A/S. End date of the data protection: 23.4.2025. |
Unflavoured pasteurised and unflavoured sterilised (including UHT) milk products |
1,0 g/l |
||||
Unflavoured fermented milk-based products |
1,0 g/l (beverages) 10 g/kg (products other than beverages) |
||||
Flavoured fermented milk-based products including heat-treated products |
1,0 g/l (beverages) 10 g/kg (products other than beverages) |
||||
Beverages (flavoured drinks) |
1,0 g/l |
||||
Cereal bars |
10 g/kg |
||||
Infant formula as defined under Regulation (EU) No 609/2013 |
0,8 g/l in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Follow-on formula as defined under Regulation (EU) No 609/2013 |
0,6 g/l in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Processed cereal-based food, baby food for infants and young children as defined under Regulation (EU) No 609/2013 |
0,6 g/l (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer 5 g/kg for products other than beverages |
||||
Milk based drinks and similar products intended for young children |
0,6 g/l (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer 5 g/kg for products other than beverages |
||||
Total diet replacement foods for weight control as defined under Regulation (EU) No 609/2013 |
2,0 g/l (beverages) 20 g/kg (products other than beverages) |
||||
Food for special medical purposes as defined under Regulation (EU) No 609/2013 |
In accordance with the particular nutritional requirements of the persons for whom the products are intended |
||||
Food Supplements as defined in Directive 2002/46/EC, excluding infants |
2,0 g/day for young children, children, adolescents, and adults |
||||
Lacto-N-tetraose (‘LNT’) (produced by derivative strains of E. coli BL21(DE3)) |
Specified food category |
Maximum levels (expressed as lacto-N-tetraose) |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘lacto-N-tetraose’. The labelling of food supplements containing lacto-N-tetraose (LNT) shall bear a statement that (a) they should not be consumed by children under 3 years of age; (b) they should not be used if other foods containing added lacto-N-tetraose are consumed the same day. |
|
Authorised on 24.1.2023. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: ‘Chr. Hansen A/S’, Boege Allé 10-12, 2970 Hoersholm, Denmark. During the period of data protection, the novel food Lacto-N-tetraose is authorised for placing on the market within the Union only by ‘Chr. Hansen A/S’ unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of ‘Chr. Hansen A/S’. End date of the data protection: 24.1.2028. |
Infant formula as defined under Regulation (EU) No 609/2013 |
1,82 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Follow-on formula as defined under Regulation (EU) No 609/2013 |
1,82 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Processed cereal-based foods and baby foods for infants and young children as defined under Regulation (EU) No 609/2013 |
1,82 g/L or 1,82 g/kg in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Milk based drinks and similar products intended for young children |
1,82 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Foods for special medical purposes for infants and young children as defined under Regulation (EU) No 609/2013 |
In accordance with the particular nutritional requirements of the infants and young children for whom the products are intended but in any case not higher than 1,82 g/L or 1,82 g/kg in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer. |
||||
Foods for special medical purposes as defined under Regulation (EU) No 609/2013 excluding foods for infants and young children |
In accordance with the particular nutritional requirements of the persons for whom the products are intended |
||||
Food supplements as defined in Directive 2002/46/EC, for the general population, excluding infants and young children |
4,6 g/day |
||||
Lonicera caerulea L. berries (haskap) (Traditional food from a third country) |
Not specified |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘haskap (Lonicera caerulea) berries’ |
|
|
|
Lucerne leaf extract from Medicago sativa |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Lucerne (Medicago sativa) protein’ or ‘Alfalfa (Medicago sativa) protein’. |
|
|
Food supplements as defined in Directive 2002/46/EC |
10 g/day |
||||
Lycopene |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Lycopene’ |
|
|
Fruit/vegetable juice-based drinks (including concentrates) |
2,5 mg/100 g |
||||
Drinks intended to meet the expenditure of intense muscular effort especially for sportsmen |
2,5 mg/100 g |
||||
Total diet replacement for weight control as defined in Regulation (EU) No 609/2013 and meal replacements for weight control |
8 mg/meal |
||||
Breakfast cereals |
5 mg/100 g |
||||
Fats and dressings |
10 mg/100 g |
||||
Soups other than tomato soups |
1 mg/100 g |
||||
Bread (including crispy breads) |
3 mg/100 g |
||||
Foods for special medical purposes as defined in Regulation (EU) No 609/2013 |
In accordance with the particular nutritional requirements of the persons for whom the products are intended |
||||
Food supplements as defined in Directive 2002/46/EC |
15 mg/day |
||||
Lycopene from Blakeslea trispora |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Lycopene’ |
|
|
Fruit/vegetable juice-based drinks (including concentrates) |
2,5 mg/100 g |
||||
Drinks intended to meet the expenditure of intense muscular effort especially for sportsmen |
2,5 mg/100 g |
||||
Total diet replacement for weight control as defined in Regulation (EU) No 609/2013 and meal replacements for weight control |
8 mg/meal |
||||
Breakfast cereals |
5 mg/100 g |
||||
Fats and dressings |
10 mg/100 g |
||||
Soups other than tomato soups |
1 mg/100 g |
||||
Bread (including crispy breads) |
3 mg/100 g |
||||
Foods for special medical purposes as defined in Regulation (EU) No 609/2013 |
In accordance with the particular nutritional requirements of the persons for whom the products are intended |
||||
Food supplements as defined in Directive 2002/46/EC |
15 mg/day |
||||
Lycopene from tomatoes |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Lycopene’ |
|
|
Fruit/vegetable juice-based drinks (including concentrates) |
2,5 mg/100 g |
||||
Drinks intended to meet the expenditure of intense muscular effort especially for sportsmen |
2,5 mg/100 g |
||||
Total diet replacement for weight control as defined in Regulation (EU) No 609/2013 and meal replacements for weight control |
8 mg/meal |
||||
Breakfast cereals |
5 mg/100 g |
||||
Fats and dressings |
10 mg/100 g |
||||
Soups other than tomato soups |
1 mg/100 g |
||||
Bread (including crispy breads) |
3 mg/100 g |
||||
Foods for special medical purposes as defined in Regulation (EU) No 609/2013 |
In accordance with the particular nutritional requirements of the persons for whom the products are intended |
||||
Food supplements as defined in Directive 2002/46/EC |
15 mg/day |
||||
Lycopene oleoresin from tomatoes |
Specified food category |
Maximum levels of lycopene |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Lycopene oleoresin from tomatoes’ |
|
|
Fruit/vegetable juice-based drinks (including concentrates) |
2,5 mg/100 g |
||||
Drinks intended to meet the expenditure of intense muscular effort especially for sportsmen |
2,5 mg/100 g |
||||
Total diet replacement for weight control covered by Regulation (EU) No 609/2013 and meal replacements for weight control |
8 mg/meal |
||||
Breakfast cereals |
5 mg/100 g |
||||
Fats and dressings |
10 mg/100 g |
||||
Soups other than tomato soups |
1 mg/100 g |
||||
Bread (including crispy breads) |
3 mg/100 g |
||||
Foods for special medical purposes as defined in Regulation (EU) No 609/2013 |
In accordance with the particular nutritional requirements of the persons for whom the products are intended |
||||
Hen egg white lysozyme hydrolysate |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of food supplements containing it shall be ‘Hen egg white lysozyme hydrolysate’. |
|
|
Food supplements as defined in Directive 2002/46/EC intended for adult population |
1000 mg/day |
||||
Magnesium citrate malate |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Magnesium citrate malate’ |
|
|
Food Supplements as defined in Directive 2002/46/EC |
|
||||
Magnolia Bark Extract |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Magnolia Bark Extract’ |
|
|
Mints (confectionary products) |
0,2 % for breath freshening purposes. Based on a 0,2 % maximum incorporation level and a maximum gum/mint size of 1,5 g each, each gum or mint serving will contain no more than 3 mg of magnolia bark extract. |
||||
Chewing gum |
|||||
Maize-germ oil high in unsaponifiable matter |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Maize-germ oil extract’ |
|
|
Food Supplements as defined in Directive 2002/46/EC |
2 g/day |
||||
Chewing gum |
2 % |
||||
Methylcellulose |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Methylcellulose’ |
Methylcellulose is not to be used in foods specially prepared for young children |
|
Edible ices |
2 % |
||||
Flavoured drinks |
|||||
Flavoured or unflavoured fermented milk products |
|||||
Cold desserts (dairy, fat, fruit, cereal, egg-based products) |
|||||
Fruit preparations (pulps, purees or compotes) |
|||||
Soups and broths |
|||||
1-Methylnicotinamide chloride |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘1- Methylnicotinamide chloride’. Food supplements containing 1-Methylnicotinamide shall bear the following statement: This food supplement should be consumed by adults only excluding pregnant and lactating women |
|
Authorised on 2 September 2018. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: Pharmena SA, Wolczanska 178, 90 530 Lodz, Poland. During the period of data protection the novel food 1-methylnicotinamide chloride is authorised for placing on the market within the Union only by Pharmena S.A. unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Pharmena S.A. End date of the data protection: 2 September 2023 |
Food Supplements as defined in Directive 2002/46/EC for the adult population excluding pregnant and lactating women |
58 mg/day |
||||
(6S)-5-methyltetrahydrofolic acid, glucosamine salt |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘(6S)-5-methyltetrahydrofolic acid, glucosamine salt’ or ‘5MTHF-glucosamine’ |
|
|
Food Supplements as defined in Directive 2002/46/EC as a source of folate |
|
|
|
|
|
Monomethylsilanetriol (Organic Silicon) |
Specified food category |
Maximum levels of silicon |
The designation of the novel food on the labelling of the food supplements containing it shall be ‘Organic silicon (monomethylsilanetriol)’ |
|
|
Food Supplements as defined in Directive 2002/46/EC for adult population (in liquid form) |
10,40 mg/day |
||||
Mung bean (Vigna radiata) protein |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘mung bean protein from Vigna radiata’. |
|
Authorised on 15 May 2022. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: Eat Just, Inc., 2000 Folsom Street San Francisco, CA 94110 USA. During the period of data protection, the novel mung bean protein is authorised for placing on the market within the Union only by Eat Just, Inc., unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Eat Just, Inc. End date of the date protection: 15 May 2027. |
Protein products |
20 g/100 g |
||||
Mycelial extract from Shiitake mushroom (Lentinula edodes) |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘extract from the mushroom Lentinula edodes’ or ‘extract from Shiitake mushroom’ |
|
|
Bread products |
2 ml/100 g |
||||
Soft drinks |
0,5 ml/100 ml |
||||
Ready prepared meals |
2,5 ml per meal |
||||
Foods based on yoghurt |
1,5 ml/100 ml |
||||
Food supplements as defined in Directive 2002/46/EC |
2,5 ml per day dose |
||||
Nicotinamide riboside chloride |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘nicotinamide riboside chloride’. |
|
Authorised on 20 February 2020. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: ChromaDex Inc., 10900 Wilshire Boulevard Suite 600, Los Angeles, CA 90024 USA. During the period of data protection, the novel food is authorised for placing on the market within the Union only by ChromaDex Inc. unless a subsequent applicant obtains authorisation for that novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of ChromaDex Inc. End date of the data protection: 20 February 2025. |
Food supplements as defined in Directive 2002/46/EC |
300 mg/day for the adult population, excluding pregnant and lactating women 230 mg/day for pregnant and lactating women |
||||
Foods for special medical purposes as defined by Regulation (EU) No 609/2013 for the adult population, excluding pregnant and lactating women |
In accordance with the particular nutritional requirements of the persons for whom the products are intended |
1. The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘nicotinamide riboside chloride’ 2. The labelling of foodstuffs containing the novel food shall bear a statement that those foods should only be consumed by persons above 18 years of age excluding pregnant and lactating women. |
|
|
|
Total diet replacement for weight control as defined by Regulation (EU) No 609/2013 for the adult population, excluding pregnant and lactating women |
500 mg/day |
||||
Meal replacements for the adult population, excluding pregnant and lactating women |
150 mg/meal (maximum 2 meals/day up to a maximum of 300 mg/day) |
||||
Noni fruit juice (Morinda citrifolia) |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Noni juice’ or ‘Juice of Morinda citrifolia’ |
|
|
Pasteurised fruit and fruit nectar based drinks |
30 ml with one serving (up to 100 % noni juice) or 20 ml twice a day, not more than 40 ml per day |
||||
Noni fruit juice powder (Morinda citrifolia) |
Food supplements as defined in Directive 2002/46/EC |
6,6 g/day (equivalent to 30 ml of noni juice) |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Noni juice powder’ or ‘Juice powder of Morinda citrifolia’ |
|
|
Noni fruit puree and concentrate (Morinda citrifolia) |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be: For fruit puree: ‘Morinda citrifolia fruit puree’ or ‘Noni fruit puree’ For fruit concentrate: ‘Morinda citrifolia fruit concentrate’ or ‘Noni fruit concentrate’ |
|
|
|
Fruit puree |
||||
Candy/confectionery |
45 g/100 g |
||||
Cereal bars |
53 g/100 g |
||||
Powdered nutritional drink mixes (dry weight) |
53 g/100 g |
||||
Carbonated beverages |
11 g/100 g |
||||
Ice cream & sorbet |
31 g/100 g |
||||
Yoghurt |
12 g/100 g |
||||
Biscuits |
53 g/100 g |
||||
Buns, cakes and pastries |
53 g/100 g |
||||
Breakfast cereals (wholegrain) |
88 g/100 g |
||||
Jams and jellies in accordance with Directive 2001/113/EC |
133 g/100 g Based on pre-processing quantity to produce final 100 g product |
||||
Sweet spreads, fillings and icings |
31 g/100 g |
||||
Savoury sauces, pickles, gravies and condiments |
88 g/100 g |
||||
Food Supplements as defined in Directive 2002/46/EC |
26 g/day |
||||
|
Fruit concentrate |
||||
Candy/Confectionery |
10 g/100 g |
||||
Cereal bars |
12 g/100 g |
||||
Powdered nutritional drink mixes (dry weight) |
12 g/100 g |
||||
Carbonated beverages |
3 g/100 g |
||||
Ice cream & sorbet |
7 g/100 g |
||||
Yoghurt |
3 g/100 g |
||||
Biscuits |
12 g/100 g |
||||
Buns, cakes and pastries |
12 g/100 g |
||||
Breakfast cereals (wholegrain) |
20 g/100 g |
||||
Jams and jellies in accordance with Directive 2001/113/EC |
30 g/100 g |
||||
Sweet spreads, fillings and icings |
7 g/100 g |
||||
Savoury sauces, pickles, gravies and condiments |
20 g/100 g |
||||
Food Supplements as defined in Directive 2002/46/EC |
6 g/day |
||||
Noni leaves (Morinda citrifolia) |
Specified food category |
Maximum levels |
1. The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Noni leaves’ or ‘leaves of Morinda citrifolia’. 2. Instructions shall be given to the consumer that a cup of infusion should not be prepared with more than 1 g of dried and roasted leaves of Morinda citrifolia. |
|
|
For the preparation of infusions |
A cup of infusion to be consumed shall not be prepared with more than 1 g of dried and roasted leaves of Morinda citrifolia |
||||
Noni fruit powder (Morinda citrifolia) |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Morinda citrifolia fruit powder’ or ‘Noni fruit powder’ |
|
|
Food Supplements as defined in Directive 2002/46/EC |
2,4 g per/day |
||||
Odontella aurita microalgae |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Odontella aurita microalgae’ |
|
|
Flavoured pasta |
1,5 % |
||||
Fish soups |
1 % |
||||
Marine terrines |
0,5 % |
||||
Broth preparations |
1 % |
||||
Crackers |
1,5 % |
||||
Frozen breaded fish |
1,5 % |
||||
Oil enriched with phytosterols/phytostanols |
Specified food category |
Maximum levels of phytosterols/ phytostanols |
In accordance with Annex III.5 to Regulation (EU) No 1169/2011 |
|
|
Spreadable fats as defined in Annex VII, Part VII and Appendix II, points B and C of Regulation (EU) No 1308/2013, and excluding cooking and frying fats and spreads based on butter or other animal fat |
1. The products containing the novel food ingredient shall be presented in such a manner that they can be easily divided into portions that contain either a maximum of 3 g (in case of one portion per day) or a maximum of 1 g (in case of three portions per day) of added phytosterols/phytostanols. 2. The amount of phytosterols/phytostanols added to a container of beverages shall not exceed 3 g. 3. Salad dressings, mayonnaise and spicy sauces shall be packed as single portions. |
||||
Milk based products, such as products based on semi-skimmed and skimmed milk products, possibly with the addition of fruits and/or cereals, products based on fermented milk such as yoghurt and cheese based products (fat content ≤ 12 g per 100 g), where possibly the milk fat has been reduced and the fat or protein has been partly or fully replaced by vegetable fat or protein |
|||||
Soya drinks |
|||||
Salad dressings, mayonnaise and spicy sauces |
|||||
Oil extracted from squids |
Specified food category |
Maximum levels of DHA and EPA combined |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Squid oil’. |
|
|
Dairy products except milk-based beverages |
200 mg/100 g or for cheese products 600 mg/100 g |
||||
Dairy analogues except drinks |
200 mg/100 g or for analogues to cheese products 600 mg/100 g |
||||
Spreadable fat and dressings |
600 mg/100 g |
||||
Breakfast cereals |
500 mg/100 g |
||||
Bakery products (breads and bread rolls) |
200 mg/100 g |
||||
Cereal bars |
500 mg/100 g |
||||
Non-alcoholic beverages (including milk-based beverages) |
60 mg/100 ml |
||||
Food Supplements as defined in Directive 2002/46/EC |
3 000 mg/day for general population 450 mg/day for pregnant and lactating women |
||||
Foods for special medical purposes as defined in Regulation (EU) No 609/2013 |
In accordance with the particular nutritional requirements of the persons for whom the products intended |
||||
Total diet replacement for weight control defined in Regulation (EU) No 609/2013 and meal replacements for weight control |
200 mg/meal |
||||
Extract from Panax notoginseng and Astragalus membranaceus |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Extract from Panax notoginseng and Astragalus membranaceus’ The labelling of food supplements containing extract from Panax notoginseng and Astragalus membranaceus shall bear a statement that those food supplements should not be consumed by the population under 18 years of age and by pregnant women. |
|
Authorised on 23 December 2020. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: NuLiv Science, 1050 W. Central Ave., Building C, Brea, CA 92821, USA. During the period of data protection, the novel food is authorised for placing on the market within the Union only by NuLiv Science, unless a subsequent applicant obtains authorisation for that novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of NuLiv Science. End date of the data protection: 23 December 2025. |
Food supplements as defined in Directive 2002/46/EC for the general adult population, excluding food supplements for pregnant women |
35 mg/day |
||||
Partially defatted chia seed (Salvia hispanica) powders |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Partially defatted chia seed (Salvia hispanica) powder’ |
|
|
Powder with high protein content |
|||||
Unflavoured fermented milk products, including natural unflavoured buttermilk (excluding sterilised buttermilk) non-heat-treated after fermentation |
0,7 % |
||||
Unflavoured fermented milk products, heat-treated after fermentation |
0,7 % |
||||
Flavoured fermented milk products including heat-treated products |
0,7 % |
||||
Confectionery |
10 % |
||||
Fruit juices as defined by Directive 2001/112/EC (8) and vegetable juices |
2,5 % |
||||
Fruit nectars as defined by Directive 2001/112/EC and vegetable nectars and similar products |
2,5 % |
||||
Flavoured drinks |
3 % |
||||
Food supplements as defined in Directive 2002/46/EC excluding food supplements for infants and young children |
7,5 g/day |
||||
Powder with high fibre content |
|||||
Confectionery |
4 % |
||||
Fruit juices as defined by Directive 2001/112/EC and vegetable juices |
2,5 % |
||||
Fruit nectars as defined by Directive 2001/112/EC and vegetable nectars and similar products |
4 % |
||||
Flavoured drinks |
4 % |
||||
Food supplements as defined in Directive 2002/46/EC excluding food supplements for infants and young children |
12 g/day |
||||
Partially defatted rapeseed powder from Brassica rapa L. and Brassica napus L. |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Partially defatted Rapeseed powder’. Any foodstuff containing ‘Partially defatted Rapeseed powder’ from Brassica rapa L. and Brassica napus L.’ shall bear a statement that this ingredient may cause allergic reaction to consumers who are allergic to mustard and products thereof. That statement shall appear in close proximity to the list of ingredients. |
|
|
Cereal bars mixed |
20 g/100 g |
||||
Muesli and similar breakfast cereals |
20 g/100 g |
||||
Extruded breakfast cereal products |
20 g/100 g |
||||
Snacks (excluding potato crisps) |
15 g/100 g |
||||
Breads and rolls with added special ingredients (such as seeds, raisins, herbs) |
7 g/100 g |
||||
Brown breads bearing statements on the absence or reduced presence of gluten in accordance with the requirements of Commission Implementing Regulation (EU) No 828/2014 |
7 g/100 g |
||||
Multigrain bread and rolls |
7 g/100 g |
||||
Meat substitutes |
10 g/100 g |
||||
Meat balls |
10 g/100 g |
||||
Pasteurised fruit-based preparations produced using high-pressure treatment |
Specified food category |
Maximum levels |
The wording ‘pasteurised by high-pressure treatment’ shall be displayed next to the name of the fruit preparations as such and in any product in which it is used |
|
|
Types of fruit: apple, apricot, banana, blackberry, blueberry, cherry, coconut, fig, grape, grapefruit, mandarin, mango, melon, peach, pear, pineapple, prune, raspberry, rhubarb, strawberry |
|
||||
Pea and rice protein fermented by Lentinula edodes (Shiitake mushroom) mycelia |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Pea and rice protein fermented by Shiitake mushroom mycelia’. |
|
Authorised on 24.1.2023. This inclusion is based on proprietary scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: MycoTechnology, Inc., 18250 E. 40th Avenue, Suite 50, Aurora, 80011 Colorado, United States. During the period of data protection, the novel food pea and rice protein fermented by Lentinula edodes (Shiitake mushroom) mycelia is authorised for placing on the market within the Union only by MycoTechnology, Inc. unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of MycoTechnology, Inc. End date of the data protection: 24.1.2028. |
Bakery wares, breads, rolls, croutons, pizza |
5 g/100 g |
||||
Breakfast cereals and cereal bars |
33 g/100 g |
||||
Fruit- and vegetable-based drinks |
20 g/100 ml |
||||
Ready-to-mix beverage powders |
93 g/100 g |
||||
Cocoa and chocolate confectionary |
7 g/100 g |
||||
Dairy analogues and non-dairy meal replacements for weight control |
11 g/100 g |
||||
Fermented milk-based products |
5 g/100 g |
||||
Pasta-based products |
15 g/100 g |
||||
Meat preparations and meat products |
14 g/100 g |
||||
Soups (ready-to-eat) and soup concentrates or powders |
3 g/100 g |
||||
Salads |
26 g/100 g |
||||
Meat analogues |
40 g/100 g |
||||
Milk-based drinks |
1 g/100 g |
||||
Single meal replacements for weight control |
1 g/100 g |
||||
Phenylcapsaicin |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘phenylcapsaicin’. |
|
Authorised on 19 December 2019. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: aXichem AB, Södergatan 26, SE 211 34, Malmö Sweden. During the period of data protection, the novel food phenylcapsaicin is authorised for placing on the market within the Union only by aXichem AB, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of aXichem AB. |
Foods for special medical purposes as defined under Regulation (EU) No 609/2013 excluding foods for infants, young children and children under the age of 11 years |
2,5 mg/day |
||||
Food supplements as defined in Directive 2002/46/EC intended for the general population, excluding children under the age of 11 years |
2,5 mg/day |
||||
Phosphated maize starch |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Phosphated maize starch’ |
|
|
Baked bakery products |
15 % |
||||
Pasta |
|||||
Breakfast cereals |
|||||
Cereal bars |
|||||
Phosphated wheat starch |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Phosphated wheat starch’. |
|
|
Baked bakery products |
15 % |
||||
Pasta |
|||||
Breakfast cereals |
|||||
Cereal bars |
|||||
Phosphatidylserine from fish phospholipids |
Specified food category |
Maximum levels of phosphatidylserine |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Fish phosphatidylserine’ |
|
|
Beverages based on yoghurt |
50 mg/100 ml |
||||
Powders based on milk powders |
3 500 mg/100 g (equivalent to 40 mg/100 ml ready to drink) |
||||
Foods based on yoghurt |
80 mg/100 g |
||||
Cereal bars |
350 mg/100 g |
||||
Chocolate based confectionary |
200 mg/100 g |
||||
Foods for special medical purposes as defined in Regulation (EU) No 609/2013 |
In compliance with Regulation (EU) No 609/2013 |
||||
Food supplements as defined in Directive 2002/46/EC |
300 mg/day |
||||
Phosphatidylserine from soya phospholipids |
Specified food category |
Maximum levels of phosphatidylserine |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Soya phosphatidylserine’ |
|
|
Beverages based on yoghurt |
50 mg/100 ml |
||||
Powders based on milk powder |
3,5 g/100 g (equivalent to 40 mg/100 ml ready to drink) |
||||
Foods based on yoghurt |
80 mg/100 g |
||||
Cereal bars |
350 mg/100 g |
||||
Chocolate based confectionary |
200 mg/100 g |
||||
Foods for special medical purposes as defined in Regulation (EU) No 609/2013 |
In compliance with Regulation (EU) No 609/2013 |
||||
Phospholipid product containing equal amounts of phosphatidylserine and phosphatidic acid |
Specified food category |
Maximum levels of phosphatidylserine |
The designation of the novel food on the labelling of the foodstuffs containing shall be ‘Soy phosphatidylserine and phosphatidic acid’ |
The product is not intended to be marketed to pregnant or breast-feeding women |
|
Breakfast cereals |
80 mg/100 g |
||||
Cereal bars |
350 mg/100 g |
||||
Foods based on yogurt |
80 mg/100 g |
||||
Soy-based yogurt-like products |
80 mg/100 g |
||||
Yogurt based-drinks |
50 mg/100 g |
||||
Soy-based yogurt-like drinks |
50 mg/100 g |
||||
Powders based on milk powder |
3,5 g/100 g (equivalent to 40 mg/100 ml ready-to drink) |
||||
Food Supplements as defined in Directive 2002/46/EC |
800 mg/day |
||||
Foods for special medical purposes as defined in Regulation (EU) No 609/2013 |
In compliance with Regulation (EU) No 609/2013 |
||||
Phospholipides from egg yolk |
Specified food category |
Maximum levels |
|
|
|
Not specified |
|||||
Phytoglycogen |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Phytoglycogen’ |
|
|
Processed foods |
25 % |
||||
Phytosterols/phytostanols |
Specified food category |
Maximum levels |
In accordance with Annex III.5 of Regulation (EU) No 1169/2011 |
|
|
Rice drinks |
1. They shall be presented in such a manner that they can be easily divided into portions that contain either a maximum of 3 g (in case of 1 portion/day) or a maximum of 1 g (in case of 3 portions/day) of added phytosterols/phytostanols. The amount of phytosterols/phytostanols added to a container of beverages shall not exceed 3 g. Salad dressings, mayonnaise and spicy sauces shall be packed as single portions |
||||
Rye bread with flour containing ≥ 50 % rye (wholemeal rye flour, whole or cracked rye kernels and rye flakes) and ≤ 30 % wheat; and with ≤ 4 % added sugar but no fat added. |
|||||
Salad dressings, mayonnaise and spicy sauces. |
|||||
Soya drink |
|||||
Milk type products, such as semi-skimmed and skimmed milk type products, possibly with the addition of fruits and/or cereals, where possibly the milk fat has been reduced, or where milk fat and/or protein has been partly or fully replaced by vegetable fat and/or protein. |
|||||
Products based on fermented milk such as yoghurt and cheese type products (fat content < 12 % per 100 g), where possibly the milk fat has been reduced, or where milk fat and/or protein has been partly or fully replaced by vegetable fat and/or protein |
|||||
Spreadable fats as defined in Annex VII, Part VII and Appendix II, points B and C of Regulation (EU) No 1308/2013, and excluding cooking and frying fats and spreads based on butter or other animal fat. |
|||||
Food Supplements as defined in Directive 2002/46/EC |
3 g/day |
||||
Plum kernel oil |
Specified food category |
Maximum levels |
|
|
|
For frying and as seasoning |
In line with normal food use of vegetable oils |
||||
Potato proteins (coagulated) and hydrolysates thereof |
Not specified |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Potato protein’ |
|
|
|
Prolyl oligopeptidase (enzyme preparation) |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Prolyl oligopeptidase’ |
|
|
Food Supplements as defined in Directive 2002/46/EC for general adult population |
120 PPU/day (2,7 g of enzyme preparation/day) (2 × 106 PPI/day) PPU – Prolyl Peptidase Units or Proline Protease Units PPI – Protease Picomole International |
||||
Protein extract from pig kidneys |
Specified food category |
Maximum levels |
|
|
|
Food Supplements as defined in Directive 2002/46/EC |
3 capsules or 3 tablets/day; equalising 12,6 mg pig kidney extract a day Diamine oxidase (DAO) content: 0,9 mg/day (3 capsules or 3 tablets with a content of DAO of 0,3 mg/capsule or 0,3 mg/tablet) |
||||
Food for special medical purposes as defined in Regulation (EU) No 609/2013 |
|||||
Pyrroloquinoline quinone disodium salt |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Pyrroloquinoline quinone disodium salt’. Food supplements containing Pyrroloquinoline quinone disodium salt shall bear the following statement: This food supplement should be consumed by adults only excluding pregnant and lactating women |
|
Authorised on 2 September 2018. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: Mitsubishi Gas Chemical Company, Inc., Mitsubishi Building 5-2 Marunouchi 2-chome, Chiyoda-ku, Tokyo 100-8324, Japan. During the period of data protection the novel food Pyrroloquinoline quinone disodium salt is authorised for placing on the market within the Union only by Mitsubishi Gas Chemical Company, Inc., unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Mitsubishi Gas Chemical Company, Inc. End date of the data protection: 2 september 2023 |
Food Supplements as defined in Directive 2002/46/EC intended for the adult population, excluding pregnant and lactating women |
20 mg/day |
||||
Rapeseed oil high in unsaponifiable matter |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Rapeseed oil extract’ |
|
|
Food Supplements as defined in Directive 2002/46/EC |
1,5 g per portion recommended for daily consumption |
||||
Rapeseed Protein |
As a vegetable protein source in foods except in infant formula and follow-on formula |
|
1. The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Rapeseed protein’. 2. Any foodstuff containing ‘rapeseed protein’ shall bear a statement that this ingredient may cause allergic reaction to consumers who are allergic to mustard and products thereof. Where relevant, this statement shall appear in close proximity to the list of ingredients. |
|
|
Refined shrimp peptide concentrate |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘refined shrimp peptide concentrate’. |
|
Authorised on 20 November 2018. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: Marealis AS., Stortorget 1, Kystens Hus, 2nd floor, N-9008 Tromsø Postal address: P.O. Box 1065, 9261 Tromsø, Norway. During the period of data protection the novel food refined shrimp peptide concentrate is authorised for placing on the market within the Union only by Marealis AS unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Marealis AS. End date of the data protection: 20 November 2023. |
Food Supplements as defined in Directive 2002/46/EC for the adult population |
1 200 mg/day |
||||
Trans-resveratrol |
Specified food category |
Maximum levels |
1. The designation of the novel food on the labelling of the food supplements containing it shall be ‘Trans-resveratrol’. 2. The labelling of food supplements containing trans-resveratrol shall bear a statement that people using medicines should only consume the product under medical supervision. |
|
|
Food supplements as defined in Directive 2002/46/EC for the adult population |
150 mg/day |
||||
Trans-resveratrol (microbial source) |
Specified food category |
Maximum levels |
1. The designation of the novel food on the labelling of the food supplements containing it shall be ‘Trans-resveratrol’. 2. The labelling of food supplements containing trans-resveratrol shall bear a statement that people using medicines should only consume the product under medical supervision. |
|
|
Food supplements as defined in Directive 2002/46/EC |
In line with normal use in food supplements of resveratrol extracted from Japanese knotweed (Fallopia japonica) |
||||
Rooster comb extract |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Rooster comb extract’ or ‘Cockerel comb extract’ |
|
|
Milk-based drinks |
40 mg/100 g or mg/100 ml |
||||
Milk based fermented drinks |
80 mg/100 g or mg/100 ml |
||||
Yoghurt-type products |
65 mg/100 g or mg/100 ml |
||||
Fromage frais |
110 mg/100 g or mg/100 ml |
||||
Sacha inchi oil from Plukenetia volubilis |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Sacha inchi oil (Plukenetia volubilis)’ |
|
|
As for linseed oil |
In line with normal food use of linseed oil |
||||
Salatrims |
Specified food category |
Maximum levels |
1. The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘reduced energy fat (salatrims)’. 2. There shall be a statement that excessive consumption may lead to gastro-intestinal disturbance. 3. There shall be a statement that the products are not intended for use by children. |
|
|
Bakery products and confectionary |
|
||||
Schizochytrium sp. oil rich in DHA and EPA |
Specified food category |
Maximum levels of DHA and EPA combined |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘DHA and EPA-rich oil from the microalgae Schizochytrium sp.’ |
|
|
Food supplements as defined in Directive 2002/46/EC for the adult population excluding pregnant and lactating women |
3 000 mg/day |
||||
Food supplements as defined in Directive 2002/46/EC for pregnant and lactating women |
450 mg/day |
||||
Foods for special medical purposes as defined in Regulation (EU) No 609/2013 |
In accordance with the particular nutritional requirements of the persons for whom the products are intended |
||||
Total diet replacement for weight control as defined in Regulation (EU) No 609/2013 and meal replacements for weight control |
250 mg/meal |
||||
Milk-based drinks and similar products intended for young children |
200 mg/100 g |
||||
Processed cereal based food and baby food for infants and young children as defined in Regulation (EU) No 609/2013 |
|||||
Foods intended to meet the expenditure of intense muscular effort, especially for sportsmen |
|||||
Foods bearing statements on the absence or reduced presence of gluten in accordance with the requirements of Commission Implementing Regulation (EU) No 828/2014 |
|||||
Bakery products (breads, rolls and sweet biscuits) |
|||||
Breakfast cereals |
500 mg/100 g |
||||
Cooking fats |
360 mg/100 g |
||||
Dairy analogues, except drinks |
600 mg/100 g for cheese; 200 mg/100 g for soy and imitation milk products (excluding drinks) |
||||
Dairy products except milk-based drinks |
600 mg/100 g for cheese; 200 mg/100 g for milk products (including milk, fromage frais and yoghurt products; excluding drinks) |
||||
Non-alcoholic beverages (including dairy analogue and milk-based drinks) |
80 mg/100 g |
||||
Cereal/nutrition bars |
500 mg/100 g |
||||
Spreadable fats and dressings |
600 mg/100 g |
||||
Fish analogues |
300 mg/100 g |
||||
Meat analogues |
300 mg/100 g |
||||
Schizochytrium sp. (ATCC PTA-9695) oil |
Specified food category |
Maximum levels of DHA |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Oil from the microalgae Schizochytrium sp.’ |
|
|
Dairy products except milk-based drinks |
200 mg/100 g or for cheese products 600 mg/100 g |
||||
Dairy analogues except drinks |
200 mg/100 g or for analogues to cheese products 600 mg/100 g |
||||
Spreadable fats and dressings |
600 mg/100 g |
||||
Breakfast cereals |
500 mg/100 g |
||||
Food Supplements as defined in Directive 2002/46/EC |
250 mg DHA/day for general population |
||||
450 mg DHA/day for pregnant and lactating women |
|||||
Total diet replacement for weight control as defined in Regulation (EU) No 609/2013 and meal replacements for weight control |
250 mg/meal |
||||
Milk-based drinks and similar products intended for young children |
200 mg/100 g |
||||
Foods intended to meet the expenditure of intense muscular effort, especially for sportsmen |
|||||
Foods bearing statements on the absence or reduced presence of gluten in accordance with the requirements of Commission Implementing Regulation (EU) No 828/2014 |
|||||
Foods for special medical purposes as defined in Regulation (EU) No 609/2013 |
In accordance with the particular nutritional requirements of the persons for whom the products are intended |
||||
Bakery products (breads, rolls, and sweet biscuits) |
200 mg/100 g |
||||
Cereal bars |
500 mg/100 g |
||||
Cooking fats |
360 mg/100 g |
||||
Non-alcoholic beverages (including dairy analogue and milk-based drinks) |
80 mg/100 ml |
||||
Infant formula and follow-on formula as defined in Regulation (EU) No 609/2013 |
In accordance with Regulation (EU) No 609/2013 |
||||
Processed cereal-based foods and baby foods for infants and young children as defined in Regulation (EU) No 609/2013 |
200 mg/100 g |
|
|||
Fruit/vegetable puree |
100 mg/100 g |
||||
Schizochytrium sp. (FCC-3204) oil |
Specified food category |
Maximum levels of DHA |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Oil from the microalgae Schizochytrium sp.’. The labelling of food supplements containing Schizochytrium sp. (FCC-3204) oil shall bear a statement that they should not be consumed by infants and children under 3 years of age. |
|
|
Infant formula and follow-on formula as defined in Regulation (EU) No 609/2013 |
In accordance with Regulation (EU) No 609/2013 |
||||
Food supplements as defined in Directive 2002/46/EC for the general population above 3 years of age |
1 g/day |
||||
Schizochytrium sp. oil |
Specified food category |
Maximum levels of DHA |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Oil from the microalgae Schizochytrium sp.’ |
|
|
Dairy products except milk-based drinks |
200 mg/100 g or for cheese products 600 mg/100 g |
||||
Dairy analogues except drinks |
200 mg/100 g or for analogues to cheese products 600 mg/100 g |
||||
Spreadable fat and dressings |
600 mg/100 g |
||||
Breakfast cereals |
500 mg/100 g |
||||
Food Supplements as defined in Directive 2002/46/EC |
250 mg DHA/day for general population |
||||
450 mg DHA/day for pregnant and lactating women |
|||||
Total diet replacement for weight control as defined in Regulation (EU) No 609/2013 and meal replacements for weight control |
250 mg/meal |
||||
Milk-based drinks and similar products intended for young children |
200 mg/100 g |
||||
Processed cereal-based foods and baby foods for infants and young children as defined in Regulation (EU) No 609/2013 |
|||||
Foods intended to meet the expenditure of intense muscular effort, especially for sportsmen |
|||||
Foods bearing statements on the absence or reduced presence of gluten in accordance with the requirements of Implementing Regulation (EU) No 828/2014 |
|||||
Foods for special medical purposes as defined in Regulation (EU) No 609/2013 |
In accordance with the particular nutritional requirements of the persons for whom the products are intended |
||||
Bakery products (breads, rolls, and, sweet biscuits) |
200 mg/100 g |
||||
Cereal bars |
500 mg/100 g |
||||
Cooking fats |
360 mg/100 g |
||||
Non-alcoholic beverages (including dairy analogue and milk-based drinks) |
80 mg/100 ml |
||||
Fruit/vegetable puree |
100 mg/100 g |
||||
Schizochytrium sp. (T18) oil |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Oil from the microalgae Schizochytrium sp.’. |
|
|
Dairy products except milk-based drinks |
200 mg/100 g or for cheese products 600 mg/100 g |
||||
Dairy analogues except drinks |
200 mg/100 g or for analogues to cheese products 600 mg/100 g |
||||
Spreadable fats and dressings |
600 mg/100 g |
||||
Breakfast cereals |
500 mg/100 g |
||||
Food supplements as defined in Directive 2002/46/EC |
250 mg DHA/day for general population |
||||
450 mg DHA/day for pregnant and lactating women |
|||||
Total diet replacement for weight control as defined in Regulation (EU) No 609/2013 and meal replacements for weight control |
250 mg/meal |
||||
Milk-based drinks and similar products intended for young children |
200 mg/100 g |
||||
Foods intended to meet the expenditure of intense muscular effort, especially for sportsmen |
|||||
Foods bearing statements on the absence or reduced presence of gluten in accordance with the requirements of Commission Implementing Regulation (EU) No 828/2014 |
|||||
Foods for special medical purposes as defined in Regulation (EU) No 609/2013 |
In accordance with the particular nutritional requirements of the persons for whom the products are intended |
||||
Bakery products (breads, rolls and, sweet biscuits) |
200 mg/100 g |
||||
Cereal bars |
500 mg/100g |
||||
Cooking fats |
360 mg/100 g |
||||
Non-alcoholic beverages (including dairy analogue and milk-based drinks) |
80 mg/100 ml |
||||
Infant formula and follow-on formula as defined in Regulation (EU) No 609/2013 |
In accordance with Regulation (EU) No 609/2013 |
||||
Processed cereal-based foods and baby foods for infants and young children as defined in Regulation (EU) No 609/2013 |
200 mg/100 g |
||||
Fruit/vegetable puree |
100 mg/100 g |
||||
Schizochytrium sp. (WZU477) oil |
Specified food category |
Maximum levels of DHA |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Oil from the microalgae Schizochytrium sp.’ |
|
Authorised on 16 May 2021. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: Progress Biotech bv, Canaalstaete, Kanaalweg 33, 2903LR Capelle aan den Ijssel, the Netherlands. During the period of data protection, the novel food is authorised for placing on the market within the Union only by Progress Biotech bv unless a subsequent applicant obtains authorisation for that novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Progress Biotech bv. End date of the data protection: 16 May 2026 (5 years). |
Infant formula and follow-on formula as defined in Regulation (EU) No 609/2013 |
In accordance with Regulation (EU) No 609/2013 |
||||
Selenium-containing yeast (Yarrowia lipolytica) biomass |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘selenium-containing yeast (Yarrowia lipolytica) biomass’. The labelling of food supplements containing selenium-containing yeast (Yarrowia lipolytica) biomass shall bear a statement that the food supplements should not be consumed by infants and children under 4 years of age/children under 7 years of age/children under 11 years of age/children and adolescents under 18 years of age (3). |
|
|
Food supplements as defined in Directive 2002/46/EC (12), excluding food supplements for infants and children under 4 years of age |
50 mg/day for children from 4 to 6 years of age, resulting in 10 μg of selenium per day 100 mg/day for children from 7 to 10 years of age, resulting in 20 μg of selenium per day 500 mg/day for adolescents from 11 to 17 years of age, resulting in 100 μg of selenium per day 800 mg/day for adults, resulting in 160 μg of selenium per day |
||||
3'-Sialyllactose (3'-SL) sodium salt (microbial source) |
Specified food category |
Maximum levels (expressed as 3'-Sialyllactose) |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘3'-Sialyllactose sodium salt’. The labelling of food supplements containing 3'-Sialyllactose sodium salt shall bear a statement that they should not be consumed: a) if foods containing added 3'-Sialyllactose sodium salt are consumed the same day. b) by infants and young children |
|
Authorised on 18 February 2021. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: Glycom A/S, Kogle Allé 4, DK-2970 Hørsholm, Denmark. During the period of data protection, the novel food 3'-sialyllactose sodium salt is authorised for placing on the market within the Union only by Glycom A/S, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Glycom A/S. End date of the data protection: 18 February 2026. |
Unflavoured pasteurised and unflavoured sterilised (including UHT) milk products |
0,25 g/L |
||||
Unflavoured fermented milk-based products |
0,25 g/L (beverages) |
||||
0,5 g/kg (products other than beverages) |
|||||
Flavoured fermented milk-based products including heat-treated products |
0,25 g/L (beverages) |
||||
2,5 g/kg (products other than beverages) |
|||||
Beverages (flavoured drinks, excluding drinks with a pH less than 5) |
0,25 g/L |
||||
Cereal bars |
2,5 g/kg |
||||
Infant formula as defined in Regulation (EU) No 609/2013 |
0,2 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Follow-on formula as defined in Regulation (EU) No 609/2013 |
0,15 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Processed cereal-based food and baby food for infants and young children as defined in Regulation (EU) No 609/2013 |
0,15 g/L (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
1,25 g/kg for products other than beverages |
|||||
Milk-based drinks and similar products intended for young children |
0,15 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Total diet replacement foods for weight control as defined in Regulation (EU) No 609/2013 |
0,5 g/L (beverages) |
||||
5 g/kg (products other than beverages) |
|||||
Food for special medical purposes as defined in Regulation (EU) No 609/2013 |
In accordance with the particular nutritional requirements of the persons for whom the products are intended |
||||
Food Supplements as defined in Directive 2002/46/EC, excluding food supplements for infants and young children |
0,5 g/day |
||||
3′-Sialyllactose (‘3′-SL’) sodium salt (produced by derivative strains of E. coli BL21(DE3)) |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘3′-Sialyllactose sodium salt’. The labelling of food supplements containing 3′-Sialyllactose (3′-SL) sodium salt shall bear a statement that (a) they should not be consumed by children under 3 years of age; (b) they should not be used if other foods containing added 3′-sialyllactose sodium salt are consumed the same day. |
|
Authorised on 6 February 2023. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: ‘Chr. Hansen A/S’, Boege Allé 10-12, 2970 Hoersholm, Denmark. During the period of data protection, the novel food 3′-Sialyllactose sodium salt is authorised for placing on the market within the Union only by Chr. Hansen A/S unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of ‘Chr. Hansen A/S’. End date of the data protection: 6 February 2028. |
Infant formula as defined under Regulation (EU) No 609/2013 |
0,28 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Follow-on formula as defined under Regulation (EU) No 609/2013 |
0,28 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Processed cereal-based foods for infants and young children and baby foods for infants and young children as defined under Regulation (EU) No 609/2013 |
0,28 g/L or 0,28 g/kg in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Milk based drinks and similar products intended for young children |
0,28 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Foods for special medical purposes for infants and young children as defined under Regulation (EU) No 609/2013 |
In accordance with the particular nutritional requirements of the infants and young children for whom the products are intended but in any case not higher than 0,28 g/L or 0,28 g/kg in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer. |
||||
Foods for special medical purposes as defined under Regulation (EU) No 609/2013 excluding foods for infants and young children |
In accordance with the particular nutritional requirements of the persons for whom the products are intended |
||||
Food Supplements as defined in Directive 2002/46/EC, for the general population, excluding infants and young children |
0,7 g/day |
||||
6’-Sialyllactose (6’-SL) sodium salt (microbial source) |
Specified food category |
Maximum levels (expressed as 6’-Sialyllactose) |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘6’-Sialyllactose sodium salt’. The labelling of food supplements containing 6’-Sialyllactose (6’-SL) sodium salt shall bear a statement that they should not be consumed: a) if foods containing added 6’-Sialyllactose sodium salt are consumed on the same day. b) by infants and young children |
|
Authorised on 17 February 2021. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: Glycom A/S, Kogle Allé 4, DK-2970 Hørsholm, Denmark. During the period of data protection, the novel food 6’-sialyllactose sodium salt is authorised for placing on the market within the Union only by Glycom A/S, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Glycom A/S. End date of the data protection: 17 February 2026. |
Unflavoured pasteurised and unflavoured sterilised (including UHT) milk products |
0,5 g/L |
||||
Unflavoured fermented milk-based products |
0,5 g/L (beverages) |
||||
2,5 g/kg (products other than beverages) |
|||||
Flavoured fermented milk-based products including heat-treated products |
0,5 g/L (beverages) |
||||
5,0 g/kg (products other than beverages) |
|||||
Beverages (flavoured drinks, excluding drinks with a pH less than 5) |
0,5 g/L |
||||
Cereal bars |
5,0 g/kg |
||||
Infant formula as defined under Regulation (EU) No 609/2013 |
0,4 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Follow-on formula as defined under Regulation (EU) No 609/2013 |
0,3 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Processed cereal-based food and baby food for infants and young children as defined under Regulation (EU) No 609/2013 |
0,3 g/L (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
2,5 g/kg for products other than beverages |
|||||
Milk based drinks and similar products intended for young children |
0,3 g/L (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Total diet replacement foods for weight control as defined under Regulation (EU) No 609/2013 |
1,0 g/L (beverages) |
||||
10,0 g/kg (products other than beverages) |
|||||
Food for special medical purposes as defined under Regulation (EU) No 609/2013 |
In accordance with the particular nutritional requirements of the persons for whom the products are intended |
||||
Food Supplements as defined in Directive 2002/46/EC, excluding food supplements for infants and young children |
1,0 g/day |
||||
6’-Sialyllactose (‘6′-SL’) sodium salt (produced by derivative strains of E. coli BL21(DE3)) |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘6′-Sialyllactose sodium salt’. The labelling of food supplements containing 6′-Sialyllactose (6′-SL) sodium salt shall bear a statement that (a) they should not be consumed by children under 3 years of age; (b) they should not be consumed if other foods containing added 6′-sialyllactose sodium salt are consumed the same day. |
|
Authorised on 4 June 2023. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: ‘Chr. Hansen A/S’, Bøge Allé 10-12, 2970 Hoersholm, Denmark. During the period of data protection, the novel food 6′-Sialyllactose sodium salt is authorised for placing on the market within the Union only by Chr. Hansen A/S unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of ‘Chr. Hansen A/S’. End date of the data protection: 4 June 2028. |
Infant formula as defined under Regulation (EU) No 609/2013 |
0,70 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Follow-on formula as defined under Regulation (EU) No 609/2013 |
0,70 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Processed cereal-based foods for infants and young children and baby foods for infants and young children as defined under Regulation (EU) No 609/2013 |
0,70 g/L or 0,70 g/kg in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Milk based drinks and similar products intended for young children |
0,70 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer |
||||
Foods for special medical purposes for infants and young children as defined under Regulation (EU) No 609/2013 |
In accordance with the particular nutritional requirements of the infants and young children for whom the products are intended but in any case not higher than 0,70 g/L or 0,70 g/kg in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer. |
||||
Foods for special medical purposes as defined under Regulation (EU) No 609/2013 excluding foods for infants and young children |
In accordance with the particular nutritional requirements of the persons for whom the products are intended |
||||
Food Supplements as defined in Directive 2002/46/EC, for the general population, excluding infants and young children |
1,8 g/day |
||||
Syrup from Sorghum bicolor (L.) Moench (Traditional food from a third country) |
Not specified |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Sorghum (Sorghum bicolor) syrup’ |
|
|
|
Fermented soybean extract |
Specified food category |
Maximum levels |
1. The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Fermented soybean extract’. 2. The labelling of food supplements containing fermented soybean extract shall bear a statement that persons taking medication should only consume the product under medical supervision. |
|
|
Food Supplements as defined in Directive 2002/46/EC (capsules, tablets or powder form) intended for the adult population, excluding pregnant and lactating women |
100 mg/day |
||||
Spermidine-rich wheat germ extract (Triticum aestivum) |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the food supplements containing it shall be ‘spermidine-rich wheat germ extract’ |
|
|
Food Supplements as defined in Directive 2002/46/EC intended for the adult population, excluding pregnant and lactating women |
Equivalent of max. 6 mg/day spermidine |
||||
Sucromalt |
Specified food category |
Maximum levels |
1. The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Sucromalt’. 2. The designation of the novel food on the labelling shall be accompanied by indication that the product is a source of glucose and fructose. |
|
|
Not specified |
|||||
Sugar cane fibre |
Specified food category |
Maximum levels |
|
|
|
Bread |
8 % |
||||
Bakery goods |
5 % |
||||
Meat and muscle products |
3 % |
||||
Seasonings and spices |
3 % |
||||
Grated cheeses |
2 % |
||||
Special diet foods |
5 % |
||||
Sauces |
2 % |
||||
Beverages |
5 % |
||||
Sugars obtained from cocoa (Theobroma cacao L.) pulp |
Not specified |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘sugars obtained from cocoa (Theobroma cacao L.) pulp’, ‘Glucose obtained from cocoa (Theobroma cacao L.) pulp’ or ‘Fructose obtained from cocoa (Theobroma cacao L.) pulp’, depending on the form used. |
|
|
|
Sunflower oil extract |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Sunflower oil extract’ |
|
|
Food Supplements as defined in Directive 2002/46/EC |
1,1 g/day |
||||
Synsepalum dulcificum dried fruits |
Specified food category |
Maximum levels |
1. The designation of the novel food on the labelling of food supplements containing it shall be ‘dried Synsepalum dulcificum fruits’ 2. The labelling of food supplements containing Synsepalum dulcificum dried fruits shall bear a statement that this food supplement should be consumed by adults only excluding pregnant and lactating women. |
|
Authorised on 5 December 2021. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: Medicinal Gardens S.L. Marqués de Urquijo 47, 1° D, Office 1, Madrid, 28008, Spain. During the period of data protection, the novel food is authorised for placing on the market within the Union only by Medicinal Gardens S.L. unless a subsequent applicant obtains authorisation for that novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Medicinal Gardens S.L. End date of the data protection: 5 December 2026. |
Food Supplements as defined in Directive 2002/46/EC for adult population excluding pregnant and lactating women |
0,7 g/day |
||||
Tetrahydrocurcuminoids |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘tetrahydrocurcuminoids’. The labelling of food supplements containing tetrahydrocurcuminoids shall bear a statement that a) they should be consumed by adults only, excluding pregnant and lactating women; b) they should not be consumed if other food supplements containing curcumin and/or curcuminoids are consumed on the same day. |
|
Authorised on 11 July 2022. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: ‘Sabinsa Europe GmbH’, Monzastrasse 4, 63225 Langen, Germany. During the period of data protection, the novel food tetrahydrocurcuminoids is authorised for placing on the market within the Union only by ‘Sabinsa Europe GmbH’ unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of ‘Sabinsa Europe GmbH’. End date of the data protection: 11 July 2027. |
Food Supplements as defined in Directive 2002/46/EC for the adult population, excluding pregnant and lactating women |
140 mg/day |
||||
Dried Tenebrio molitor larva (yellow mealworm) |
Specified food category |
Maximum levels |
1. The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Dried Tenebrio molitor larva (yellow mealworm)’. 2. The labelling of the foodstuffs containing dried Tenebrio molitor larva (yellow mealworm) shall bear a statement that this ingredient may cause allergic reactions to consumers with known allergies to crustaceans and products thereof, and to dust mites. This statement shall appear in close proximity to the list of ingredients. |
|
Authorised on 22 June 2021. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: SAS EAP Group, 35 Boulevard du Libre Échange, 31650 Saint-Orens-de-Gameville, France. During the period of data protection, the novel food is authorised for placing on the market within the Union only by SAS EAP Group, unless a subsequent applicant obtains authorisation for that novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283, or with the agreement of SAS EAP Group. End date of the data protection: 22 June 2026. |
Dried Tenebrio molitor larva, whole or in powder |
|
||||
Protein products |
10 g/100 g |
||||
Biscuits |
10 g/100 g |
||||
Legumes-based dishes |
10 g/100 g |
||||
Pasta-based products |
10 g/100 g |
||||
Dried Tetraselmis chuii microalgae |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Dried microalgae Tetraselmis chuii’ or ‘Dried microalgae T. chuii’ Food supplements containing dried microalgae Tetraselmis chuii shall bear the following statement: ‘Contains negligible amounts of iodine’ |
|
|
Sauces |
20 % or 250mg/day |
||||
Special salts |
1 % |
||||
Condiment |
250 mg/day |
||||
Food Supplements as defined in Directive 2002/46/EC |
250 mg/day |
||||
Therapon barcoo/Scortum |
Intended use identical to that of the salmon, namely the preparation of culinary fish products and dishes, including cooked, raw, smoked and baked fish products |
|
|
|
|
D-Tagatose |
Specified food category |
Maximum levels |
1. The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘D-Tagatose’. 2. The labelling of any product where the level of D-Tagatose exceeds 15 g per serving and all beverages containing greater than 1 % D-Tagatose (as consumed) shall bear a statement ‘excessive consumption may produce laxative effects’. |
|
|
Not specified |
|||||
Taxifolin-rich extract |
Specified food category |
Maximum levels |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘taxifolin-rich extract’ |
|
|
Yogurt plain/Yogurt with fruits(*) |
0,020 g/kg |
||||
Kephir(*) |
0,008 g/kg |
||||
Buttermilk(*) |
0,005 g/kg |
||||
Milk powder(*) |
0,052 g/kg |
||||
Cream(*) |
0,070 g/kg |
||||
Sour cream(*) |
0,050 g/kg |
||||
Cheese(*) |
0,090 g/kg |
||||
Butter(*) |
0,164 g/kg |
||||
Chocolate confectionery |
0,070 g/kg |
||||
Non-alcoholic beverages |
0,020 g/L |
||||
Food supplements as defined in Directive 2002/46/EC intended for the general population, excluding infants, young children, children and adolescents younger than 14 years |
100 mg/day |
||||
(*) When used in milk products Taxifolin-rich extract may not replace in whole or in part, any milk constituent |
|||||
Trehalose |
Specified food category |
Maximum levels |
1. The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Trehalose’ and shall be displayed on the labelling of the product as such or in the list of ingredients of foodstuffs containing it. 2. The designation of the novel food on the labelling shall be accompanied by indication that the ‘Trehalose is a source of glucose’. |
|
|
Not specified |
|||||
UV-treated mushrooms (Agaricus bisporus) |
Specified food category |
Maximum levels of vitamin D2 |
1. The designation on the label of the novel food as such or of the foodstuffs containing it shall be ‘UV-treated mushrooms (Agaricus bisporus)’. 2. The designation on the label of the novel food as such or of the foodstuffs containing it shall be accompanied by indication that a ‘controlled light treatment was used to increase vitamin D levels’ or ‘UV treatment was used to increase vitamin D2 levels’. |
|
|
Mushrooms (Agaricus bisporus) |
20 μg of vitamin D2/100 g fresh weight |
||||
UV-treated baker’s yeast (Saccharomyces cerevisiae) |
Specified food category |
Maximum levels of vitamin D2 |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘vitamin D yeast’ or ‘vitamin D2 yeast’ |
|
|
Yeast-leavened breads and rolls |
5 μg/100 g |
||||
Yeast-leavened fine bakery wares |
5 μg/100 g |
||||
Food supplements as defined in Directive 2002/46/EC |
In accordance with Directive 2002/46/EC |
||||
Pre-packed fresh or dry yeast for home baking |
45 μg/100 g for fresh yeast 200 μg/100 g for dried yeast |
1. The designation of the novel food on the labelling of the foodstuffs shall be ‘vitamin D yeast’ or ‘vitamin D2 yeast’. 2. The labelling of the novel food shall bear a statement that the foodstuff is only intended for baking and that it should not be eaten raw. 3. The labelling of the novel food shall bear instructions for use for the final consumers so that a maximum concentration of 5 μg/100 g of vitamin D2 in final home-baked products is not exceeded. |
|||
Dishes, incl. ready-to-eat meals (excluding soups and salads) |
3 μg/100 g |
The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘vitamin D yeast’ or ‘vitamin D2 yeast’ |
|||
Soups and salads |
5 μg/100 g |
||||
Fried or extruded cereal, seed or root-based products |
5 μg/100 g |
||||
Infant formula and follow-on formula as defined by Regulation (EU) No 609/2013 |
In accordance with Regulation (EU) No 609/2013 |
||||
Processed cereal-based food as defined by Regulation (EU) No 609/2013 |
In accordance with Regulation (EU) No 609/2013 |
||||
Processed fruit products |
1,5 μg/100 g |
||||
Processed vegetables |
2 μg/100 g |
||||
Bread and similar products |
5 μg/100 g |
||||
Breakfast cereals |
4 μg/100 g |
||||
Pasta, doughs and similar products |
5 μg/100 g |
||||
Other cereal based products |
3 μg/100 g |
||||
Spices, seasonings, condiments, sauce ingredients, dessert sauces/toppings |
10 μg/100 g |
||||
Protein products |
10 μg/100 g |
||||
Cheese |
2 μg/100 g |
||||
Dairy dessert and similar products |
2 μg/100 g |
||||
Fermented milk or fermented cream |
1,5 μg/100 g |
||||
Dairy powders and concentrates |
25 μg/100 g |
||||
Milk based products, whey and cream |
0,5 μg/100 g |
||||
Meat and dairy analogues |
2,5 μg/100 g |
||||
Total diet replacement for weight control as defined by Regulation (EU) No 609/2013 |
5 μg/100 g |
||||
Meal replacements for weight control |
5 μg/100 g |
||||
Foods for special medical purposes as defined in Regulation (EU) No 609/2013 |
In accordance with the particular nutritional requirements of the persons for whom the products are intended |
||||
UV-treated bread |
Specified food category |
Maximum levels of vitamin D2 |
The designation on the label of the novel food shall be accompanied by ‘contains vitamin D produced by UV-treatment’ |
|
|
Yeast leavened bread and rolls (without toppings) |
3 μg vitamin D2/100 g |
||||
UV-treated milk |
Specified food category |
Maximum levels of vitamin D3 |
1. The designation on the label of the novel food shall be ‘UV-treated’. 2. Where UV-treated milk contains an amount of vitamin D that is considered significant in accordance with Point 2 of Part A of Annex XIII to Regulation (EU) No 1169/2011 of the European Parliament and of the Council, the designation for the labelling shall be accompanied by ‘contains vitamin D produced by UV-treatment’ or ‘milk containing vitamin D resulting from UV-treatment’. |
|
|
Pasteurised whole milk as defined in Regulation (EU) No 1308/2013 to be consumed as such |
5-32 μg/kg for general population excluding infants |
||||
Pasteurised semi-skimmed milk as defined in Regulation (EU) No 1308/2013 to be consumed as such |
1-15 μg/kg for general population excluding infants |
||||
Vitamin D2 mushroom powder |
Specified food category |
Maximum levels of vitamin D2 () |